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Influenza, commonly called "flu", is one of the oldest and most common 
diseases known to man. Few diseases exert so great an influence on health and 
economic loss during a major epidemic year. Hong Kong being one of the densest 
populated cities in the world must have incurred heavy losses due to flu, and flu-like 
illnesses (FFLI). Employees working in enclosed areas with bad ventilation were 
especially at high risk to this illness. 
This study was designed to measure the health and cost impacts of FFLI on 
individuals, employers and society. Questionnaires were completed by 2,212 subjects 
of a big airline corporation in Hong Kong. Samples were divided into three groups 
according to their working environments. 
About 60% of the respondents had contracted FFLI during the flu season in 
February, March and April of 2001. 80% of them admitted that FFLI had affected 
their work performance and normal activities. A relatively high level of consultation 
with western doctors was reported. As this is a Chinese society, some participants 
used Chinese medicine or visited Chinese medicine practitioners. 
i i i 
In this ample population, on average each employee required 1.03 days of sick 
leave and lost 11.05 days of perfect health in each FFLI episode. An individual also 
incurred a loss of HK$7,394.35 in productivity for each FFLI. Hypothesis testing 
supports our hypothesis that working condition is a risk factor to the illness. 
Employees working in congested environment with poor ventilation incurred the 
largest health loss (12.62 days) and productivity loss (HK$9,369.20). The quality of 
work environment was directly related to the incidence, health and productivity loss 
of working adults. To the company, the associated loss of profit from FFLI was 
estimated to be 6.74%. From society's point of view, a loss of 8.8 days per employee 
per year translated to a loss of2.41% of Hong Kong GDP. The potential GDP in 2000, 
in the absence of FFLI, would have been HK$l,298,468million. 
In view of the considerable impact of FFLI on worker productivity and the 
considerable associated economic cost to employers and society, a study of the 
differential impacts of it on workers in different work environments would be 
important in developing future healthcare policies and preventive programs. 
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CHAPTER ONE INTRODUCTION 
Influenza, commonly called "flu", is one of the oldest and most common diseases 
known to man. People infected with flu only have short-term symptoms and will usually 
recover within a week. This conveys to the public the perception that flu is a mild 
disease, and thus the impact of it is generally underestimated. Although medications and 
surveillance programs against influenza are being undertaken in modem societies, few 
other diseases match influenza in its impact on absenteeism, suffering, normal activity 
disruption and economic loss during a major epidemic year. 
According to the World Health Statistics Quarterly, an estimated 9% of the world 
population may contract symptomatic influenza each year. In the U.S., flu was 
responsible for more than 2,000 million days of restricted activity, 100 million days of 
confinement to bed, 75 million days of work absenteeism and 22 million days of health 
care provider visits in 1995. ‘ Since flu is a communicable disease, it is highly 
transmittable in populations inhabiting in enclosed spaces. Hence, people of all ages in 
Hong Kong, which is one of the most densely populated cities in the world, are highly 
susceptible to this illness and the resulting health and cost impacts of flu and flu-like 
illnesses could be substantial. According to government statistics, 92.5 per 1000 
consultations were for flu and flu-like illnesses, as reported by General Out-patient 
Clinic (GOPC) and General Practitioners (GP) in February 2000，or 9.25% of all cases.� 
The 1997 avian flu in Hong Kong heightened awareness of the danger of this highly 
‘Source: The National Health Interview Survey 
2 Source: Government Of Hong Kong Special Administrative Region Department of Health 
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transmittable illness. A study confirmed that flu and flu-like illnesses impaired workers' 
reaction time and their productivity, implying that they affected not only the individual, 
but also the economy and society as a whole�. As Hong Kong's economy is dominated 
by labour intensive industries, the health impact of FFLI could lead to serious 
productivity losses. As no study has ever been conducted to investigate the effects of 
FFLI on a well-defined working population in Hong Kong, a study of this nature would 
be important in outlining ftiture preventive policies. In addition, airborne diseases 
often predominate among crowded populations in enclosed spaces, and thus workers 
working in crammed conditions belong to high-risk groups. It would be interesting to 
study the impact of flu among workers in different working environments. 
In Hong Kong, influenza has always been known as flu and so the terms "flu" 
and "flu-like illness" (FFLI) are used in this study instead of the terms influenza and 
influenza-like illness. The aims of this research are first, to measure the incidence and 
health impact of FFLI on the working population of a big airline corporation in Hong 
Kong and second, to quantify its indirect cost impact on the employers and society. 
Nearly everyone has experienced FFLI, but not everyone understands its impact 
on the individual and society. Its ability to kill stems from the fact that the virus can 
mutate quickly and can produce new strains against which humans have no immunity. 
When this occurs, mortality from FFLI can be staggering. For example, during the 
"Spanish flu" pandemic of 1918-1920, at least 20 million people died from flu. In 1997， 
3 Refer to Smith et al 1993 
2 
there was an epidemic of avian flu in Hong Kong, in which the disease was transmitted 
from chickens and ducks to humans in. Fortunately, the virus did not spread from 
person to person, and soon died out after the reservoir of domestic birds was completely 
depleted. The Hong Kong authorities killed approximately 1.6 million chickens, ducks 
and geese in that exercise. 
Flu virus constantly mutates, and periodically causes worldwide pandemics to 
which almost everyone is susceptible. In fact, it is so unpredictable that no one knows 
when the next pandemic will occur. 
Recently a lot of attention has been given to the cost-benefit analysis of FFLI 
vaccination. Indeed, vaccination has been confirmed to be effective in reducing the 
illness among the elderly and healthcare workers, both suspected to be high-risk groups 
to FFLI. However, its effectiveness on working adults is still controversial. Nichol et al 
(1995) showed that there would be a net benefit of US$46.85 (1995 value) in 
vaccinating adults at the workplace; though it did not lead to any cost savings in the 
Bridges et al. (2000) study. In this double-blind controlled trial's study, if vaccination 
cost was included, it would not be beneficial, whether the vaccination matched the 
circulating vims or not. Fitzner et al. (2001) analyzed flu prevention in Hong Kong. 
They concluded that medical, social and monetary costs of FFLI in Hong Kong were 
not high compared to other more developed countries. However, vaccination was not 
socially cost-effective even when targeted at special groups. By using different 
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methodologies and sample sizes, the above studies did not yield consistent results in 
terms of economic losses. Keech et al (1998) studied the effect of FFLI on working 
adults amonga group of working adults in a UK factory. A questionnaire was used to 
collect information from participants during their FFLI episode. Simple statistical 
analyses were used to investigate the productivity loss and healthcare resource 
utilization. Significant cost and productivity impacts resulting from FFLI were found. 
On average, 2.8 days of missed work per person were found in the samples and 
workers' daily activities were affected to a certain extent. 
In the present research, the study design is similar to that of Keech et al (1998). 
The samples were drawn from a Hong Kong-based company and part of the results was 
expressed in dollar terms to quantify the FFLI effect. A questionnaire was developed to 
collect data from employees. It was designed to collect information on employees' 
demography, FFLI nature and duration. The flu season covered in this study was 
February to April 2001, and questions were asked about the episode during this period 
and also about the latest one. Respondents were divided into three groups in accordance 
with by their working environments. The hypothesis is that working adults in workplace 
with poor ventilation would induce higher FFLI incidence and productivity loss. 
Investigation was focused on the attack rate, health and cost impact from the illness. 
Indirect cost was evaluated with self-established estimator and statistical analysis was 
conducted to test. This project was sponsored by Roche Group in a form of 
unconditional donation. Therefore, analysis was conducted with complete freedom and 
independence. 
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CHAPTER TWO BACKGROUND AND LITERA TURE REVIEW 
(2.1) Background Review 
2.1.1 Flu and flu-like illness 
Influenza, - first described by Hippocrates and is also known as flu, derived its 
name from eighteenth century Italians who blamed its influence on the heavenly bodies. 
It is a contagious disease caused by the flu virus which attacks the respiratory tract in 
humans. Its onset can be sudden and symptoms include fever, sore throat, runny nose, 
muscle ache and fatigue. People of all ages can be infected. As it is difficult to identify 
clinically flu from other acute respiratory illnesses laboratory tests are therefore 
necessary for exact diagnosis. This disease can become deadly as the virus can mutate 
quickly into new strains that can be those against which human beings have no 
immunity. 
Flu A and B viruses are the most common types circulating among the human 
population. The least common type is the flu C virus. Flu A can be divided into 
subtypes based on two proteins on the surface of the virus. They are hemagglutinin (H) 
and neuraminidase (N). Current subtypes found in people are A (HlNl) and A (H3N2), 
and they are often included in each year's flu vaccine. For flu B, there are no subtypes. 
Since type C only causes mild respiratory illness and is not thought to cause epidemics, 
flu shots do not protect people from this type of virus. 
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The flu virus can change in two different ways at irregular intervals. 
"Antigenic drift" refers to small changes in the virus that happen continually over time. 
"Antigenic shift" occurs only occasionally, but when this does happen, most people 
have little or no protection against the new virus. Shift is an abrupt, major change in the 
flu A virus where new subtypes develop on the surface protein of the virus. 
The flu A vims is also found in many different animals such as birds, pigs, ducks, 
whales, horses and seals. Almost all the subtypes of flu A, totaling 21 types, can be 
found in wild birds but they do not become ill from the virus. However, fowls that are 
domestically reared get very sick if they are infected. Evidence suggests that human 
beings very rarely get flu infections directly from animals and most epidemics occur 
because of the flu spreading from person to person. 
The transmission media of flu are mainly air and humans. Crowdedness in 
enclosed areas is one main factor for the spread of airborne flu. When a person with flu 
coughs, sneezes, or speaks and sends the flu virus into the air, other people inhale the 
virus. The virus enters the nose, throat or lung and begins to multiply and cause 
symptoms of flu. After getting a flu, a person can spread the vims from the first day 
before feeling sick and this continues for about three to seven days; children can spread 
the flu virus for more than seven days. Even an infected person with no flu symptoms 
can spread the virus. The flu virus enters the body and symptoms will occur in one to 
four days. 
6 
The clinical symptoms of flu are often rapid in onset and include fever, headache, 
chills, muscle ache, fatigue and weakness, sneezing, stuff nose, runny nose, sore throat 
and cough. Sometimes the potential complications can be severe, such as pneumonia, 
bronchitis, sinus and ear infections. To patients with an underlying illness, flu worsens 
the chronic health problem. 
Currently, the main approach to controlling FFLI and its associated costs is the 
administration of vaccines. Every year, the World Health Organization recommends the 
appropriate vaccine composition to be used for the next season. Several groups of 
people are at risk from flu-related complications and they are recommended for flu 
shots; they are (a) people with chronic health conditions, (b) the elderly-65 years old or 
a b o v e inc lud ing t h o s e e n j o y i n g g o o d health, ( c ) those w h o h a v e c l o s e contact w i t h 
chronic-illness patients, such as healthcare workers and their family members'^. The 
cost-benefit analysis of vaccination for healthy working adult is reviewed in the 
following section. 
2.1.2 Pandemics 
Since the 1580 flu pandemic, there have been 31 documented pandemics around 
the world including three major pandemics in the twentieth centuryl These pandemics 
were caused by minor changes in the flu viral antigenic proteins. Worldwide pandemics 
4 Source: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 
5 Source: World Health Organization 
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occur only occasionally, but they can affect large portions of the population due to the 
absence of immunity against the new virus. When a new subtype of flu virus appears 
after an antigenic shift, it can spread easily from person to person. The most serious 
pandemics in the twentieth century were the 1918 "Spanish flu", the 1957 "Asian flu" 
and the 1968 "Hong Kong flu". 
The 1918-19 "Spanish flu" had the highest number of known flu deaths in 
history. Outbreaks caused by the new vims exploded almost simultaneously in three 
different locations: France, Sierra Leone and Boston and soon rocketed to the farthest 
points of the globe. In half a year, 33,387 people were killed in New York, accounting 
for 1% of the city's population. In that pandemic, 500,000 people died in the U.S., 40 
million died worldwide and the disaster affected half of the world's population. People 
died within the first few days after infection and some died of complications soon after. 
This "worst plague in history" affected mainly young and healthy adults. 
The 1957-58 "Asian flu" caused approximately 70,000 deaths in the U.S. It was 
identified in late 1957 in China and soon spread to the U.S. within four months. 
In 1968, a new flu type (Influenza A H3N2) was discovered in Hong Kong, and 
was named "Hong Kong flu" after it became a pandemic. It was first detected in Hong 
Kong in early 1968 and it spread to the U.S. later that year. There were approximately 
34,000 deaths in the U.S. 
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Evidence showed that the virus which caused these epidemics originated from 
animals; "Spanish flu" emanated from swines while the other two originated from birds. 
The "Asian flu" and "Hong Kong flu" killed more than 1.5 million people and there was 
an estimated US$32 billion (1997 value) in economic losses, including both 
productivity loss and medical expenses. 
Since flu cannot be identified clinically, during inter-pandemic periods, flu virus 
strain isolation and identification are crucial for the surveillance and control of the 
disease. A new virus type may evolve against which human beings have no immunity, 
and this can cause the next pandemic. 
2.1.3 Global preventive program 
Since 1948，the World Health Organization (WHO) has coordinated a global alert 
system against flu 6. It aims to develop routine surveillance activities and control 
methods to limit the spread, severity and consequences of the epidemic disease. 
Information is collected continuously from around the world to supervise flu virus 
activities. Flu virus isolated data are also collected to enable WHO to formulate 
recommendations for vaccine manufacturers regarding the compositions of flu vaccines 
to be used. There are 110 national flu centers and 4 WHO collaborating centers for 
reference and research in Australia, Japan, the U.K. and the U.S. Since September 2000， 
6 Source: World Health Organization 
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a new invention called FluAid, 2.0 has become available from the National Vaccine 
Program Office's World-Wide Web site. This software specializes in estimating the 
number of deaths, hospitalizations, and outpatient visits that may occur during the next 
pandemic. It helps policy planners prepare for the resources necessary in a flu pandemic. 
2.1.4 The Hong Kong scenario 
Hong Kong is situated in the sub-tropical zone, with flu prevailing all year round. 
In a recent study, it WAS found that the flu attack rate in Hong Kong was about 11% a 
year?，or about 770 thousand residents were affected every year^. Direct medical costs 
as well as indirect costs (such as work day loss and productivity loss) attributable to flu 
could be very high although they are not as high as those in more developed countries. 
Most Hong Kong people lack physical exercise and a balance diet, leading to low body 
resistance to illnesses. Moreover long working hours and stressful lifestyles, together 
with a crowded and polluted environment, also contributed to higher FFLI incidences in 
Hong Kong. 
As Hong Kong lies within the hypothetical flu epicenter for the emergence of 
pandemic viruses, flu virus develops easily and transmissions occur very fast. Though it 
spreads widely and can attack almost every individual in the city, there are few records 
of flu-attributable hospitalizations and deaths in the 1980s and early 1990s. Because of 
7 Refer to Fitzner et al. 2001 
8 Calculate with 7 million population 
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the low morbidity of this disease, the impact of flu is generally overlooked. However, 
the outbreak of 'bird flu' changed people's perception and caused great public concern. 
'Bird flu' A (H5N1) virus was first discovered in terns in South Africa in 1961. In 
May 1997, the influenza A (H5N1) virus was isolated from a boy who had died of 
Reye's Syndrome. In the past, the virus was known to infect only bird species, 
especially chickens and ducks. It was the first time that the flu A (H5N1) virus was 
found in humans. The exact means of transmission of the virus to humans could not be 
identified but there was no evidence of any human-to-human transmission. It was 
believed that infection came through contact with infected birds. There had been 15 
cases of human infection with the H5N1 virus by the end of 1997, and it also caused six 
deaths between 1997 and 1998. In the end, 1.5 million chickens and other poultry were 
slaughtered after they were discovered to be the source of the virus. This stopped 
further infection in the region and eliminated the risk of transmission to other parts of 
the world. 
The Department of Health of the Hong Kong SAR government has increased the 
surveillance activity of the virus since the first outbreak, and the virus has been found in 
domestic chickens and ducks almost every year. The Hong Kong government and the 
World Health Organization are keeping in close contact to maintain proper surveillance 
activities in order to prevent it from becoming epidemic. Flu vaccination is strongly 
recommended for high-risk groups and there is an increasing demand every winter. At 
present, the elderly in institutionalized settings are being immunized every year. 
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(2.2) Literature Review - Vaccination o fFFLI 
Although FFLI is only a common disease, it can incur considerable costs to 
different countries every year. In the U.S., the flu attack rate was about 15 to 35%, and 
the annual economic cost was about US$3 billion (1987 valuef，】、Based on the attack 
rate, the projected maximum life loss was 207,000, hospitalizations 734,000 and 
outpatient visits 42 million. In the 1999 estimation, the economic impact was estimated 
to have been US$71.3 to 166.5 billion, excluding commerce and societal disruptions. 
The present study concerns the productivity impact associated with FFLI on 
healthy working adults. However, literature is mostly about influenza vaccination and 
its effectiveness. Thus, the following review studies on this topic aim to collect more 
relevant information. 
Flu vaccination is the most popular means adopted to prevent and reduce the 
health and economic impacts of the illness. Its efficacy in protecting the elderly and 
high risk patients from the disease and its complications has been well demonstrated in 
recent studies. Its efficacy has also been firmly established in randomized, controlled 
trial studies on young healthy adults. A study conducted on healthy individuals aged 
from 14 to 60 years showed that the recommended inactivated parenteral vaccines had 
an efficacy of 68%". Many developed countries have vaccination programs for the 
9 Refer to Schoenbaum SC 1987 
Refer to Meltzer et al. 1999 
“ R e f e r to Demicheli et al. 2000 
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elderly and those with medical conditions; however, no country has yet endorsed 
vaccination policy for all adults, irrespective of age or health status Evaluation of the 
economic impact of such a program is important to policy makers in making health care 
decisions concerning vaccination. Employers also need such information to support a 
company-sponsored vaccination program. 
In recent years, many studies have been carried out on the benefit of vaccination 
for the elderly or healthcare providers. Regarding these studies, most of them found that 
vaccination proved to be cost-saving for high risk groups. Apart from this, there is an 
increasing focus on vaccination against FFLI in a group of working adults with no 
underlying medical conditions. Most of the analyses adopted a social perspective, while 
some were from the employers' point of view. The research designs of these studies 
were of two types: (a) prospective controlled trial, (b) simulation in projection to a 
company or society. The following discussion is a more detailed account of these two 
types of design. 
2.2.1 Prospective controlled trial 
Nichol et al. (1995), Kumpulainen and Makela (1997), Campbell and Rumley 
(1997), and Bridges et al. (2000) studied the benefit of vaccination on working adults by 
controlled trial. Only Bridges et al. (2000) conducted the trial over two flu seasons and 
the others studied only one flu season. With the exception of Campbell and Rumley 
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(1997) who analyzed the problem from employers' perspective, all others conducted 
their investigations from a societal perspective Both Nichol et al. (1995) and Bridges et 
al. (2000) assessed the issues by randomized double-blind controlled trial. Nichol et al. 
(1995) used placebo injection while Bridges et al. (2000) used sterile saline injection as 
the alternative strategy. Kumpulainen and Makela (1997), and Campbell and Rumley 
(1997) conducted non-randomized non-placebo controlled trial using no vaccination as 
the alternative strategy. 
All of their subjects were working adults aged between 18 and 62/64, with 
median age of 45. Participants were either recruited from a local company or a district 
with a population size ranging from 262 to 1,184 working adults. The participants were 
divided into two groups, each with similar background and characteristics. One group 
was offered vaccination leaving the other group as control. Information on 
demographics and other background was obtained when they were recruited. During 
certain time intervals, participants were asked about their health status and related 
information to be recorded for further analysis. 
Case definitions were different among the studies. Nichol et al. (1995) defined 
upper respiratory illness as sore throat associated with either fever or a cough lasting for 
more than 24 hours. Serologically confirmed flu (acute and convalescent phase blood 
samples, nasopharyngeal samples) was defined as FFLI in Kumpulainen and Makela's 
studies (1997). In Campbell & Rumley,s study (1997), FFLI was defined as a 
respiratory illness having a duration of more than two days and one or more systemic 
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symptoms and respiratory tract symptoms. Bridges et al. (2000) had two definitions. In 
the first one, FFLI was defined as feverishness or a measured temperature of at least 
37.7°C (>=100°F) plus a cough or sore throat (CDC ILI surveillance definition). In the 
second one, upper respiratory illness (URI) was defined as a sore throat plus cough, 
feverishness, or a measured temperature of at least 31.TC (>=100°F). In short, though 
they defined FFLI differently, all of them related FFLI with respiratory illness. In most 
cases, they believed that fever should be one of the most common symptoms. 
The observed flu attack rates differed, from 1.6% for Kumpulainen and Makela 
(1997) to 69% for the placebo group of Nichol et al. (1995). About vaccine efficacy rate, 
Bridges et al. (2000) had a rate about 33% in the 1998-99 flu season when the vaccine 
virus matched the circulating strains. The other studies had a 24 to 65 % flu shot 
efficacy rate. Direct medical costs per case were US$3.70 (1997 value) in Finland 
(Kumpulainen and Makela 1997), while the other studies conducted in the U.S. yielded 
a value of about US$45-47 (1997 value) (Campbell and Rumpley 1997) and US$106.17 
(2000 value) (Bridges et al. 2000). The highest costs were found in Nichol et al.'s 
(1995) study which amounted to US$166.82 (2000 value). The range in indirect costs 
was even greater. In Finland, indirect costs per case were US$16.42 (1997 value). 
Campbell and Rumpley (1997) and Bridges et al. (2000) calculated the difference in 
indirect costs between the nonvaccinated and vaccinated groups to be US$30.53 (1997 
value) and US$264.49 (2000 value) respectively. The indirect cost saving found in 
Nichol et al.'s study (1995) amounted to US$485.68 (1995) per vaccine. The variances 
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between the values of the chosen parameters were large and would affect the research 
outcomes. 
As the results were estimated quite recently, the effect of inflation should have 
been small. Cost composition could explain the great differences in the outcomes. All 
the studies observed fewer episodes of URI or FFLI in the vaccinated group and Nichol 
et al. (1995), Campbell and Rumley (1997) and Bridges et al. (2000) further revealed 
that there was less work day loss and fewer physician consultations in those vaccinated 
participants. Both Nichol et al. (1995) and Campbell and Rumpley (1997) found a net 
benefit from vaccination with US$46.85 (1995 value) per vaccinee and US$2.58 (1997 
value) per dollar invested in vaccination respectively. However, Kumpulainen and 
Makela (1997) observed a net loss of US$106.59 (1997 value) per infection averted. An 
interesting result was found in Bridges et al.'s (2000) two period studies. The vaccines 
did not benefit more than the placebol group from vaccination when the vaccine virus 
did not match the circulating strain when vaccination cost was included. The loss was 
about US$65.59 and US$11.17 in 1997-98 and 1998-99 (2000 value) respectively. Net 
loss was lower in the year when the vaccine virus matched correctly the circulating one. 
It was surprising that though Nichol et al. (1995) assumed the highest underlying 
attack and cost rates, there was cost saving using vaccination. Conversely, in 
Kumpulainen and Makela (1997)，the lowest chosen parameters yielded a net loss. In 
addition, a higher vaccine efficacy (65%) was observed in Kumpulainen and Makela's 
study (1997) than that (average 34.5%) obtained in Nichol et al.'s (1995). Sample 
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characteristics and indirect costs probably contributed to these special outcomes. The 
details are listed in table A. 
2.2.2 Simulation projection 
The decision to vaccinate healthy adults was also analyzed by using simulation 
projection. Information about flu attack rate, vaccine efficacy, direct and indirect costs 
were collected from the literature, institutional authorities or by estimation. By applying 
simulation and sensitivity analyses, cost-benefit outcomes were estimated. Buckel et al. 
(1999), Nichol (2001), and Muennig and Khan (2001) investigated the problem with 
this method. Both Nichol (2001) and Muennig and Khan (2001) studied from society's 
perspective, and simulations were applied to the whole society. Buckel et al. (1999), 
however, studied this problem from the employers' viewpoint and a Brazilian pharma-
chemical company was chosen in their as a case study. Only in the case study was the 
population limited to the chosen company; the others applied to all the healthy working 
adults in a society. Avoidance of direct medical and indirect costs was the benefit of 
intervention in all the studies 
Muennig and Khan (2001) defined FFLI as fever or a measured temperature of 
>=37.7°C plus a cough or sore throat. The alternative strategies were oral oseltamivir, 
75mg b.i.d. for 5 days and provision of supportive care only as the alternative strategies. 
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There was neither a definition for FFLI nor an alternative strategy stated in the other 
two studies. 
The chosen FFLI attack rates for these studies were around 5% to 15% with a 
mean of 10%. In Burckel et al.'s (1999) study, the vaccine efficacy rate varied from 
70% to 89% depending on age and severity of illness. In Nichol's (2001) study, the rate 
depended on the matching of vaccine virus and the likelihood of matching, with 75% 
for a good match scenario, 35% a poor match scenario, and 80% the likelihood of a 
good match for any given year. However, Muennig and Khan (2001) did not state 
clearly the vaccine efficacy rate used in the study. The direct vaccine cost was US$10 
(Burckel et al. used the 1997 value; Muennig and Khan used the 1997 value; Nichol 
used the 1998 value) in all these studies. Direct and indirect costs of FFLI were 
calculated for different morbidity levels by Burckel et al. (1999). They divided the data 
into low, moderate and high morbidity levels and the direct and indirect costs associated 
were US$8 (1997 value) and one day absence, US$50 (1997 value) and three to four 
days' absence and US$160 (1997 value) and more than 6 days' absence respectively. 
The range of direct costs was US$80 to US$123 (1998 value) in Nichol's (2001) study 
but there were no clearly stated indirect costs. Muennig & Khan (2001) estimated the 
direct costs for medical office visits for FFLI to be US$64.39 (1997 value) but they did 
not state explicitly the indirect costs used in their study. Price effects should be minimal 
as the three studies used similar year values. In spite of that, different measuring factors 
and obscure costs had led to diverse conclusions. 
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FFLI incidence decreased and less work loss was reported in Burckel et al.'s 
(1999) study while fewer FFLI symptoms and a net gain of 0.00074 QALYs or 6.5 
quality-adjusted hours relative to providing supportive care were observed by Muennig 
and Khan (2001). Nichol (2001) found that there was a reduction in work day loss, 
physician visits, hospitalization rates and death rates. Net savings were reported in all 
these simulation studies. There was a gain of US$2.47 (1997 value) for every dollar 
spent on vaccination in Burckel et al.'s study (1999); and savings of US$13 (1997 value) 
and US$13.66 (1998 value) per vaccinee were reported in Muennig & Khan's (2001) 
and Nichol (2001)，s studies respectively. Though the sensitivity analysis performed in 
the studies had different sensitive variables, all of them were sensitive to the FFLI 
attack rate and vaccine cost. 
Simulation analyses produced the same results. Less FFLI incidence and cost 
savings were achieved by using flu shots. Although the studies used different assumed 
factors, they all supported the use of vaccination against flu. Hence the choice of 
variables in the study had little effect on the outcomes. See table A. 
In summary, there is disagreement on the vaccination benefit among studies using 
different study methods. The net savings from vaccination were as high as US$46.85 
(1997 value) in Campbell & Rumpley (1997)，s study but a loss as great as US$65.59 
(2000 value) was reported for Bridges et al. (2000). Although net dollar savings varied, 
almost all of the studies reported a reduction in flu attack rates, less sick leave and fewer 
physician visits. Perhaps these studies are not comparable because they were of 
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different scales and their research methods were different. There was no universal or 
consistent measure regarding the definition of FFLI. Also the compositions of direct 
and indirect costs assigned were different in all the studies. Finally the country specific 
demographic characteristics as well as the populations in the studies were also different. 
Therefore, the results might not be comparable and application of the findings to other 
populations or countries could be limited. Nonetheless, these results do provide useful 
information for future FFLI cost-benefit analysis. They can serve as reference for future 
simulation analyses to achieve greater accuracy and in the choice of variables. 
2.2.3 Study in Hong Kong 
Although Hong Kong lies in the hypothetical flu epicenter, there has been little 
research on FFLI related issues. Fitzner et al. (2001) conducted a study on flu 
prevention in Hong Kong during the period from April 1993 through March 1994. 
Adopting a societal perspective, this was a cost-effectiveness analysis using simulation 
and sensitivity analysis techniques. In this study, FFLI was defined as fever >=100°F 
(37.8°C) oral or equivalent and cough or sore throat. 
The study was divided into two phases. In the first phase, a flu database was 
developed from a five parts Influenza Monitoring Programme (IMP) to collect data. In 
phase two, decision and cost-effectiveness analyses were carried out to evaluate 
vaccination strategies. It examined the incidence and severity of FFLI in Hong Kong, 
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the direct and indirect costs arising from it, and the savings that could be made by 
implementing a vaccination scheme. 
There were several assumptions in this study. The vaccination coverage rate was 
60% for each target group where vaccine would be administered opportunistically. 
Indirect costs due to vaccination such as time for vaccination and the resulting side 
effects were excluded, while the benefit of natural immunity was discounted at 5% for 
10 years. A 60% vaccine efficacy rate was assumed. The direct costs resulting from 
FFLI were estimated at HK$270 (1993-94 value) for mild and moderate cases and 
HK$907 (1993-94 value) for severe, non-hospitalization cases. The indirect costs from 
loss of productivity were estimated at HK$20.76 (1993-94 value) for working adults, 
and HK$9 (1993-94 value) for school children. These indirect costs only existed in the 
moderate and severe cases. The direct cost for vaccination was HK$93 (1993-94 value) 
per vaccinated individual. After adjusting for the benefit net cost was about HK$74 
• (1993-94 value). 
Fitzner et al. (2001) found that the flu attack rate was 11% during the research 
period which was very close to the result estimated in previous studies. The highest 
incidence occurred among those between one and 25 years of age, while the lowest was 
found among those aged 25 and 64. Hospitalization rates were highest among the 
elderly (0.025%) and young children (0.01%). Among those infected, 79% sought 
medical care, of which 99% received medication and 27% self-treated. The overall cost 
was HK$283 (1993-94 value) per case. In economic terms, the associated costs of FFLI 
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were more than HK$187 (1993-94 value) million in Hong Kong. Vaccination for the 
elderly and those with underlying diseases was the most beneficial strategy and the 
second best was for the working population. In the sensitivity analysis, outcomes were 
not sensitive to incidence, vaccine efficacy, vaccine coverage rate and salary. In one of 
the sensitivity analysis scenarios, it would be more optimal for vaccines to be targeted 
at high value and high-pay employees. In conclusion, no cost-savings resulted from any 
vaccination program from the macro social point of view, but it was cost-effective for 
susceptible individuals. 
Due to an incomplete database, many costs and rates were estimated or taken 
from the literature. This has led to the study being limited by its many uncertainties 
because country and demographic differences would make the estimations inapplicable. 
However, this preliminary research has provided important information for decision 
making regarding the implementation of vaccination programs in Hong Kong. 
While traditional vaccination cost-benefit analysis was studied by Fitzner et al. 
(2001), the present study investigates FFLI associated productivity impact in Hong 
Kong from the employers' perspective. This study examines the indirect cost impact of 
FFLI for a group of healthy working adults. By studying the productivity loss of a group 
of employees, the findings are projected to the general working population based on 
obtained statistics. As Fitzner et al.'s (2001) objective was to study the general 
population, and thus people of all ages were included in his analysis. Data from 
institutional authorities were used by Fitzner et al. and they estimated both direct and 
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indirect costs to measure vaccination effectiveness. In the present study, a questionnaire 
was developed to collect sample statistics. . As Fitzner and the present study have 
different objectives and methodologies, different outcomes and findings regarding the 
impact of FFLI can be expected. 
(2.3) Literature Review - Social impact and productivity loss of FFLI 
2.3.1 Social impact 
FFLI not only poses a medical challenge, but also has significant social and 
economic impacts on society. When determining the overall burden of FFLI, both direct 
and indirect costs associated with it must be evaluated, as well as its incidence and 
severity. 
According to Sullivan, as immunity increased with age, most cases of FFLI 
occurred in the age group between 5 and 15. Families with children were found to have 
higher incidences because infections spread rapidly among school children. Infection 
rate was also high among the susceptible elderly and people with underlying chronic 
illnesses. Though school children were easily infected with FFLI, 5 to 24 years olds 
were the age group having the fewest severe complications and hospitalizations, 
approximately 6 per 10,000 individual. Yet, the very young (under one year) and the 
elderly experienced the highest incidence of FFLI. Other studies showed that 80% to 
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90% of annual deaths from FFLI in the U.S. occurred among those above 64 years. 
Irrespective of age, people with chronic conditions had a considerably greater likelihood 
of developing severe symptoms or complications requiring hospitalization. Incidence 
and severity of FFLI depend virtually on age and health status. 
The illness has significant direct cost impacts on the society. Healthcare resources 
including hospitalization and physician visits are ways to take care of the patients. 
Medical resources used for treatment include mainly cough and cold medications which 
contributed to 4.7 million prescriptions in 1997 in Germany. Antibiotics are also 
prescribed to treat bacterial secondary infections. The annual direct medical cost 
associated with FFLI was about U.S.$1 to 3 million (1981 value). 
The indirect burden of FFLI can even be greater than its direct cost impact, and 
was estimated by Levy to be at 80% to 90% of the total cost. Infection with FFLI can 
result in loss of productivity and the need for sick leave. Schoenbaum and Kavet found 
that patients were confined to bed for three to four days in a typical FFLI. In a Belgian 
study, the average duration of sick leave was about 7.5 days. An individual's absence 
from work can indeed bring about great loss to companies. It incurs overtime payments 
for replacement employees, medical allowance paid to absentees and administrative 
costs in managing absence and rescheduling work. At the same time, company suffers 
from loss in production and disruptions to particular sections. As the majority of costs 
can be attributed to indirect costs resulting from absenteeism and loss of productivity, 
12 Sources: Simonsen et al and, Liu and Kendal 
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employers should establish effective measures to prevent illness and provide cost-
effective medication to reduce the resulting costs. In Smith's book, he reported that 
FFLI accounted for 10% of all sickness absence from work. In Germany the estimated 
costs in a flu pandemic were mainly due to its indirect cost. In the US, indirect costs 
were estimated at US$10 to 15 billion (1981 value) a year.'^ 
In Smith et al.'s (1993) study, FFLI could impair one's performance. A mild flu 
illness reduces 20% to 40% of a person's reaction time. In contrast, alcoholic 
consumption only produced 5% to 10% reduction. This intangible costs also included 
reduction of quality of life to people as well as their families or co-workers. 
The above evidence shows that FFLI not only incurs costs to an individual, but 
also brings about significant economic loss to society. 
2.3.2 Productivity loss 
Although cost-benefit analysis of vaccination for healthy working adults has been 
carried out by many researchers, there has been only limited literature on productivity 
loss analysis. The following is a literature review on this topic. 
13 Source: Off ice o f Technology Assessment US Congress 
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Keech et al. (1998) conducted a prospective analysis among 3,417 employees of a 
large pharmaceutical company in the UK. Its objectives were to examine the variety of 
ways FFLI could affect the employees and to quantify its impact. In this study, FFLI 
was defined as feeling 'feverish' and the presence of at least two of four additional 
symptoms (headache, sore throat, myalgia or cough). Some of the employees had been 
vaccinated against flu for the current season as they were believed to be ‘at risk'. 
Participants were recruited at symptom onset when they returned to work. They 
completed a questionnaire to collect demographic, symptomatologic and health 
information and the productivity impact of FFLI. Productivity loss and healthcare 
resources utilization were estimated and simple statistical analysis was performed. 
Six hundred and twenty-eight employees with a mean age of 34.2 reported FFLI. 
There were on average 2.8 work days lost. A majority of employees confined to bed or 
incapacitated for more than two days which was lower than the average three to four 
days in other studies. For those employees who returned to work while symptomatic, 
their score in 'effectiveness at work' were only moderate and this was consistent with 
the medical study above. Half of the employees required care giver assistance and this 
cost about 0.4 days loss from their work. About 73% of participants reported that the 
illness had interfered with their normal activities at home 'all or most of the time', and 
84% reported this interfered with leisure or recreational activities 'all or most of the 
time'. On average employees needed 3.5 days for their resumption of normal activities. 
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Most of the participants chose to visit general practitioners GP (29%). In the 
sample population 95% received medication from GP or took OTC drugs. Feverishness, 
weakness and headache were the most common symptoms reported. The findings 
showed a positive correlation between number of symptoms reported and number of 
days confined to bed, and the number of symptoms reported and the number of work 
day lost. The work days lost contributed to an estimated £111,679 (1998 value) in total, 
and the total cost of lost caregiver work was £4,785 (1998 value) and the cost for GP 
visit was £14 (1998 value) on average. In addition, more senior staff returned to work 
earlier: managerial staff returned to work 1.4 days earlier than secretarial or 
administrative staff. 
Although Keech et al. (1998) analyzed FFLI during a non-epidemic year, the 
illness still incurred considerable productivity loss to employers. Other research should 
be carried out to examine the situation in different workplaces across countries. 
Research design and analyses similar to those in Keech et al's (1998) has been 
established in the present study to evaluate the impact of FFLI Both studies aimed at 
exploring FFLI's indirect impact on a group of well-defined employees. A 
questionnaire was used to collect sample information on the incidence and nature of the 
illness. Also FFLI is defined in similar ways in both studies. However, Keech et al. 
(1998) conducted serology tests to assess the flu infection. The present study has not 
included any medical tests to confirm the presence of flu antibodies, which may have 
lowered the accuracy of the findings. In addition to the indirect effect on the employees, 
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the present study tried to assess workers in a poor working environment to ascertain 
whether workplace characteristics constitute risk factors. On the other hand, other than 
simple statistic analysis, hypothesis testing was carried out to identify the difference 
among the samples. Regression and sensitivity analysis were also performed to explore 
the relationship between personal background and FFLI. 
Past pandemics have provided ample information on the nature and seriousness of 
FFLI. This has given rise to the invention of vaccines and the introduction of preventive 
courses against this disease. Many countries have already begun their analyses on the 
impact of FFLI and the vaccination effectiveness. Fitzner et al. (2001) provided a 
primary outlook regarding the illness and vaccination in Hong Kong. Since the 1997 
event, public perception of the severity of flu illnesses has changed and there has been 
more concern about its health and productivity impacts on individuals. The present 
study examines the productivity issue in detail, and aims to construct a clear picture of 
its economic impact on Hong Kong working adults. 
2 8 
CHAPTER THREE CONDUCT OF SUR VEY 
(3.1) Research design 
The study was conducted between May 2001 and June 2001. The participants 
were employees of a major Hong Kong-based international airline. A questionnaire was 
developed by professors from the School of Pharmacy and the Medical School of the 
Chinese University of Hong Kong'"^ to collect employees' demographic information, 
FFLI symptoms and its associated health and economic impacts. The flu season covered 
by this research was February to April 2001 and questions were asked about the episode 
during this period and the latest illness. FFLI was defined as the occurrence of at least 
two of the following symptoms: sore throat, sneezing, runny nose, fatigue, stuffy nose, 
cough, general aches and pains and fever. 
This survey was open to all company employees (n = 11,000), who were 
predominantly office staff, check-in staff and aircrew. Questionnaires were distributed 
to either employees' company pigeon holes or to department secretaries to be further 
redistributed among the staff one day before the survey. 
The questionnaire survey was divided into two phases. The first phase started 
from 17th May to f ^ June and office staff and aircrew were the targeted groups. During 
14 Professor Kenneth K.C. Lee from School of Pharmacy, 
Dr. Thomas Y.K. Chan, Dr. Josehp T.F. Lau from the Department of Medicine 
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this period, two booths were set up in the company building, where one was situated 
near the benefit centre and the other was in front of the aircrew leisure lobby. This 
setting was aimed at engaging employees' attention and to provide them with a 
convenient spot to return the questionnaires. Almost all of them should pass by either 
booth before they returned to their workplace. Two student helpers from the Chinese 
University of Hong Kong and two members of staff from the pharmaceutical company 
were assigned to stay at the booths during the survey period from 10:00a.m. to 5:00p.m. 
Monday to Friday. Their duties were to conduct interviews with employees to complete 
the questionnaires, answer all enquiries from participants and collect questionnaires. 
One collection box was placed at each booth so that employees could put their 
questionnaires in any time even after office hours. This arrangement catered specially 
for aircrews who had irregular working hours. The boxes were placed in the booths 
until the end of the second survey period and the helpers counted the number of 
questionnaires collected before and after each day's work. All collected questionnaires 
were stored in a safe place in the company's human resources department every day. 
The second phase was held between June and June. The survey was 
conducted in the resting room of the airline company in the Hong Kong International 
Airport at Chek Lap Kok and the targeted group consisted of all check-in staff. Two 
helpers from the Chinese University of Hong Kong stayed in the room from 10:a.m. to 
4:00p.m. Monday to Friday. They actively approached employees for a short 
questionnaire interview and collected their returns. 
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Since the response rate was low at the beginning of the survey period, the helpers 
needed to approach employees actively. The majority of the questionnaires were 
collected from interviews and the rest was by volunteer return. With the sponsorship of 
the pharmaceutical company, a specially designed pen was given to all the participants 
as a gift when they returned the questionnaires or after the interviews. 
Under the research hypothesis, the sample was divided into three groups 
according to their working environments. Group A consisted of all check-in staff, who 
worked in a well-ventilated area; Group B consisted of clerical staff, technical staff and 
managerial staff, who worked in a typical office environment; Group C consisted of 
cabin crew and cockpit crew, who worked in a congested area with poor ventilation. 
Group C was hypothetically regarded as the high-risk group in this study because their 
inferior workplace condition and job nature were deemed to be conducive to FFLI. 
Based on their working environments, the investigation was focused on whether there 
were differences between the groups in terms of incidence and impact as a result of 
FFLI. Indirect costs were estimated based on the collected data and statistical estimation, 
and hypothesis testing were conducted to evaluate the incidence of FFLI. 
Data analyses were grouped into two main parts. There was a brief summary of 
the main questions asked in the questionnaire in the first part. In the second part, 
productivity estimation was conducted to evaluate the productivity loss brought about 
by the illness. Statistical test and regression analyses were performed to test the 
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differences between the groups and the relationship between health loss and 
demographic variables. 
(3.2) Questionnaire 
The specially designed questionnaire aimed to record the incidence of FFLI, its 
associated symptoms, treatment applied by participants and its impacts on their daily 
activities and work capacity. The questionnaire was divided into three parts. Refer to 
the questionnaire in the appendix. 
The first part recorded the incidence and impact of FFLI in the past three months, 
i.e. the February to April 2001 flu season. The questions asked about the number of 
FFLI episodes and the associated impacts in each of these three months. The impact 
was assessed from the number of episodes and the impact on the following: required 
days off, affected normal level of activity at work, needed bed rest, affected 
participants' colleagues and family members. The approximate total number of days for 
which the participants could not report for work resulting from the illness during the 
three months was also asked. Days off include sick leaves and miss work days resulting 
from FFLI. 
In the second part, questions were asked about the participant's most recent FFLI 
episode which might not have occurred during the three month flu season. The date of 
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this episode was recorded and its nature, symptoms, treatment and impact were 
documented. Participants had to report the occurrence of any symptoms at the onset and 
in five to seven days. Symptoms included mild fever, high fever, chills, mild headache, 
severe headache, general aches and pains, fatigue and weakness, extreme exhaustion, 
sneezing, stuffy nose, runny nose, whitish nasal discharge, greenish or yellowish nasal 
discharge, chest discomfort, sore throat, cough, white sputum and greenish or yellowish 
sputum. They could also state any symptoms not listed above. 
The kind of treatment used was also interesting. Participants were asked to 
describe their use of health-care resources for this episode. In particular, they were to 
choose from the following: no treatment; self-treatment with over-the-counter drugs 
(OTC) for colds, vitamin supplements, Chinese herbal medicines or Chinese proprietary 
medicine; visiting western doctors or Chinese medicine practitioners. They could also 
state other treatment methods used. Reasons for choosing the specified treatment 
methods were to be chosen from the given statements. 
To investigate the effect of FFLI on the activities of the participants during the 
illness, they were asked to describe the extent to which their normal activities and work 
capacity were affected, namely no effect, mildly, moderately or severely, at the 
symptoms onset and five to seven days later. In order to further explore the impact of 
this episode, the duration with respect to the severity of symptoms and the effect on 
work capacity were also collected. Clear definitions of severity of symptoms were given, 
in which mild symptoms were defined as not affecting normal activities, moderate 
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symptoms as affecting normal activities and severe symptoms as requiring bed rest and 
sick leave. They also had to state the total days of sick leave they had taken in this 
episode. 
In addition, any hospitalization details during this episode were documented: 
whether they were admitted to hospital for reasons directly related to this episode, the 
diagnosis and duration. 
Because the company was an airline, an additional question was developed to 
study the source of the latest FFLI episode experienced by the aircrew. Since their 
duties involved flying to other countries, it was possible that their illnesses developed 
after a trip to a foreign city. The question was relevant to the aircrew only, and they had 
to specify the cities where they believed the illness had developed prior to their return . 
The last part of the questionnaire recorded participant's background information. 
They were asked about their sex, age, smoking habits and number of hours spent on 
physical exercise. They also had to give their health status so that we could have 
information on whether an individual had nasal diseases or lung/airways diseases that 
required regular medications. Participants were asked to state their annual salary to 
facilitate the calculation of productivity loss. 
For a prospective case study, questions were asked in detail to gain more 
knowledge about the illness. Most of the analyses in this study was based on the 
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information collected from this survey. Statistics for projection of economic loss for the 
company and society as a whole were obtained from company reports and government 
sources. 
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CHAPTER FOUR DA TA DESCRIPTION 
(4.1) Participants 
A total of 2,212 employees with FFLI symptoms participated in the present study, 
accounting for 20% of the total population. As some returns were incomplete, only 
2,173 samples were used, among which 344 were check-in staff - Group A (23% 
response), 923 were office staff - Group B (37% response) and 906 were aircrew -
Group C (14% response). Table 1.1 showed that most subjects in the sample were 
female (68%) and only Group B had a higher male staff proportion (43%). Overall, the 
average age of participants was 31.3 years and in each group more than half of the 
subjects were between 18 and 35 years old. The imbalance of the gender distribution 
could be explained by the fact that the majority of cabin crew and check-in staff were 
female. The custom to employ young adults to serve customers in the airline business 
has also led to the relatively young age of the sample. 
About 76% respondents (n =1851) never smoked and only 14% were current 
smokers. This might be related to the company policy that no smoking is allowed inside 
the company building where almost all of the office employees worked, and aircrew are 
not permitted to smoke on board nor at the airport. When we used the sample to project 
to the general population, this 14% would probably fall short of the true size of the 




A large number of respondents did not have any underlying illness relating to the 
respiratory system. Only 16% and 5% of the sample had a nasal disease or lung disease 
respectively. This would imply that they would be less easy to be infected with FFLI 
especially that complicating their upper respiratory system. 
Healthcare professionals have recommended that an individual should do at least 
three hours of exercises weekly in order to keep oneself in good health and build up 
body resistance. More than half of the respondents (69%, n = 2170) spent less than 2 
hours per week on physical exercise and so they would be less resistant to illnesses, 
such as FFLI. Group A spent less time on physical exercise compared to the other two 
groups. This was probably due to their long and irregular working schedules which left 
them with less time for exercise. 
Eighty percent of the respondents (n = 2132) had an annual income of between 
HK$100,000 and HK$400,000, showing that the majority of them were not in the high 
income group. 
Without further analysis, the background information would suggest that Group 
A should have less FFLI than the other two. Though most of them spent less time on 
exercise, this group had a lower average age and their working environment had the best 
ventilation. However, there was no great difference between the groups in their 
demographics and so it was still indeterminable which one would be more affected by 
the impact from FFLI. 
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(4.2) Incidence and impact of FFLI during the three month period 
(Feb-April 2001) 
Table 1.2 summarizes FFLI incidences during the three months and the associated 
impacts on each group. Only 2,172 subjects replied to questions in this part. The 
average FFLI incidence rate during the three months was 60% and the range was 54% 
to 63% between the groups. The total number of episodes was 2,303 and the average 
was 1.06 episodes per person. Group B and C had a high number of total episodes and 
episodes per person (1.10 and 1.09 respectively) than Group A. In the total sample 
population, 36% of the cases required days off, 58% affected normal levels of activity at 
work and 52% required bed rest. In most episodes, the illness had no effect upon 
colleagues or family members (78% and 71% respectively). 
The three groups were affected in similar ways by FFLI during this period. The 
higher incidence rates for Group B and C were in agreement with the hypothesis that 
poor working environment would induce more FFLI. However, the statistics did not 
indicate that these groups demanded more rest. On the other hand, the illness had 
greater impact on working activities and subjects' colleagues for Group B due to their 
stable working environment and more frequent contact with family and colleagues. 
Table 1.3 shows the total number of work days missed in this period. About half 
of the participants (48%, n = 1256) reported no days off from work and only 486 (39%) 
subjects missed half to three working days. About 14% of the respondents had missed 
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three or more days from work due to FFLI during the three months. There were 58% of 
the participants from Group A did not miss any work days, which was the highest 
among the groups, whereas for Group C, the hypothetically high risk group, 24% 
missed three days or more from work. 
On the whole, Group A had the lowest incidence rate (54%) and had the largest 
proportion of no days missed. FFLI only mildly or moderately affected employees in 
this group. Group B had the highest incidence rate (63%) but required no more days off 
than the other groups. Although Group C did not require more days off for the episodes, 
they reported more missed work days due to FFLI during the three months. This 
indicated that FFLI affected Group C more seriously as they required more days off in 
spite of having a similar incidence rate as Group B. 
(4.3) Incidence and impact of the most recent FFLI 
All participants (n = 2,173) answered questions in part two of the questionnaire 
about the details of their most recent FFLI episode. Since this reported the episode that 
had occurred most recently, some participants reported an FFLI which had occurred 
before the flu season, i.e. during February to April 2001. According to table 2.1, all 
episodes together incurred 12,627.5 days of symptoms duration (n = 2,173) and 
duration per episode was 5.81 days without taking into account symptom severity. 
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These data concurred with common experience as it only takes five to seven days for a 
person to recover from FFLI. 
Among the groups, Group B had more number of episodes in total, but Group C 
had more days of symptom duration (6,089.5 days). Since Group C had the longest 
symptom duration, it had the longest duration for each episode (6.72 days) as well 
whereas Group A had the shortest duration (4.86 days) among the groups. Group A also 
had a larger proportion of mild symptoms (52%) while Group C had a larger one in 
severe symptoms (18%). 
Employees working in well-ventilated area had shorter duration per episode than 
office staff. The group with the highest risk suffered from more severe illness and the 
degree of severity of FFLI increased with the poor condition of the working 
environment. Apart from working environment, the longer symptom duration in Group 
C was due to their long working hours for each flight. If they were on a flight and were 
infected with FFLI, they could not report for sick leave until they come back to their 
station. Without proper rest, their illness would deteriorate and extend the symptom 
duration. In contrast, the other two groups could apply for sick leave any time because 
they had a stable work place and schedule. 
The duration of different severity impact on work capacity is summarized in table 
2.2. On most of the days, employees believed FFLI did not affect or only mildly 
affected their work capacity (67%). For about one third of the time during the episode, 
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the illness did not affect employees' work capacity. Group A, B and C had about the 
same proportion of days of illness not affecting employees' normal work capacity (39%, 
38% and 37% respectively). Group C had 17% of days affecting employees' work 
severely. Group B reported quite even proportions for each degree of severity. One third 
of the time the subjects' work was moderately and severely affected and the rest was 
divided almost evenly between mildly affected and not affected. 
The work of aircrews confines them to the plane, and hence their work would be 
affected severely if they get FFLI because they walk around the plane to serve 
passengers. As seen from the above, flu also incurred longer severe symptom duration 
for these employees, which logically would bring more serious impact. Therefore 
Group C experienced more severe work capacity impact from the illness. 
On the other hand, table 2.3 shows the degree of impact on daily activities and 
work capacity at the onset and five to seven days later of the latest FFLI. Only 2167 
respondents answered this part. For the effect on daily activity, about half of the 
subjects (48%) reported that the illness had mildly affected their normal activities at the 
onset, 26% respondents said it had moderately affected and only 8% experienced severe 
effect on them. Five to seven days into the sickness, 56% had resumed their normal 
activities while 5% still reported severe impact. The impact on work capacity was quite 
similar. About 21% said it did not affect their work at the onset; 41% said it had only 
mildly affected, and 25%, moderately affected them. Severe impact on work capacity 
accounted for 13% but the same severity of impact was only 8% on daily activity. But 
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the impact on work reduced to 7% after five to seven days. 42% of the participants still 
experienced some effect on their work after five to seven days and the majority of them 
were only mildly affected. 
At the onset, there was obviously severe impact on individuals' daily activities 
and work. After five to seven days, about half of the respondents had already recovered 
and so there was no effect on their activities and work. In general, people believe that 
illness affected their work more than other activities because they need more energy and 
concentration in their work. As mentioned above, FFLI impaired individuals' 
performance and so impact on work was more significant than that on activities. 
According to table 2.4，75% of participants reported they had sore throat at the 
onset and this symptom was the most common. The other common symptoms at the 
onset were fatigue and weakness (74%), mild headache (62%), general aches and pains 
(61%), sneezing (61%), stuffy nose (60%) and runny nose (59%). After five to seven 
days, the symptoms still persisted. Common symptoms during this period were cough 
(39%), fatigue and weakness (35%), sore throat (31%), stuffy nose (28%) and runny 
nose (31%). However, most participants had already recovered after five days. 
The symptoms presented in this study were similar to those reported in Keech et 
al.'s study (1998). However, due to different FFLI definition, Keech et al. reported 97% 
feverishness whereas only 56% respondents had a fever in this study. Weakness and 
headache were the most common symptoms in both studies. 
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Table 2.5 indicates that about 72% (n=2,169) of the subjects had visited western 
doctors to treat their FFLI and some of them (22%) bought over-the-counter drugs. 
Subjects (11%) also self treated with vitamin supplements hoping to recover sooner. As 
Chinese culture predominates in Hong Kong society, a small number of participants 
also took Chinese herbal medicines (4%), bought Chinese proprietary medicines (2%) 
or visited Chinese medicine practitioners (6%). Most of them (78%) sought treatment in 
order to recover sooner and some of them (23%) hope this could prevent the illness 
from infecting the others. 
From table 2.6 and 2.7，it can be seen that only 8% did not receive any treatment. 
For those who received no treatment, the majority of them (77%) believed they would 
recover sooner or later from FFLI and treatment was not needed. 16% of them (16%) did 
not have time for any treatment and 12% believed FFLI could not be cured by treatment. 
Half of them received treatment because they could not stand the symptoms. 
The small number of subjects who sought Chinese medicine treatment was 
probably a result of the company's medical benefit system. In this company, medical 
insurance for staff covered their visits to western doctors only. To be eligible for 
reimbursement, staff would rather visit western doctors than Chinese medicine 
practitioners. As a matter of fact, visiting Chinese doctors is a common practice among 
the Chinese in Hong Kong. Hence, an educated guess would be that the figures for 
Chinese medicine treatment is underrepresented in this study. 
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As shown in table 2.8，the most recent FFLI led to an average 1.03 days of sick 
leave per person. Group A had an average of 0.52 days of sick leave while Group B and 
Group C had 0.82 days and 1.44 days respectively. Group C had more average days of 
sick leave which is consistent with previous result that participants in this group 
reported more days missed during the three month flu season. 
There were only 26 cases of hospitalization reported and 11 of them resulted from 
severe flu. Only three of them were diagnosed with pneumonia. The incidence of 
hospitalization was not high and the maximum number of days spent in hospital was 
14.5 days. See Table 2.9. 
The incidence of and severity of impact on different groups were different for 
different working environments. The above results imply that employees working in the 
confined space of an airplane had more incidences of FFLI and more severe impact on 
both daily activities and work. They had longer symptom duration and required more 
days off. Severely affected work capacity would cause serious productivity loss. 
Therefore further statistic analysis was necessary to quantify this issue. 
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CHAPTER FIVE ECONOMIC LOSS 
The above results indicated that FFLI affect employees' work capacity and thus 
their productivity. This chapter reports in detail efforts to quantify this loss and to test 
its statistical significance. Although this issue is important to company and society in 
general, no research has yet been conducted in the South China region. This information 
will help policy makers in their plans for future preventive programs. 
In this part of the study, a number of statistic analyses were performed. 
Estimators were established to measure health loss and economic loss from FFLI. 
Density estimation was performed to get more knowledge about the probability 
distribution of the estimators. To test whether there were differences between the three 
hypothetical groups, hypothesis testing and sensitivity analysis were conducted. 
Individual background information was evaluated by regression to assess its 
relationship with the estimator. Lastly, company profit loss and economic loss on a 
societal scale were projected based on the above results. 
(5.1) Estimators - EDPH loss and productivity loss 
According to Smith et al.(1993), flu type B impairs an individual's simple 
reaction time by at least 20%. In this way, FFLI has certain impact on workers' 
productivity. Most flu vaccination cost-benefit analyses measure the indirect cost of 
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illness by using the human capital approach where average labour cost and workday 
loss are estimated. Since no such studies have been carried out to investigate the 
economic cost, two estimators have been established to quantify the cost of illness. 
The first estimator is annual Equivalent Days of Perfect Health (EDPH) loss and 
it assesses the health loss associated with FFLI in terms of days. Equation 1 shows the 
calculation. 
Equation 1 
Annual Equivalent Days of Perfect Health (EDPH) loss per person 
EDPH loss = (Mi X 0.25 + M2 x 0.5 + S x 0.75 ) x 3.75 x T 
where Mi = mild symptoms duration of the latest FFLI episode 
M2 = moderate symptoms duration of the latest FFLI episode 
S = sever symptoms duration of the latest FFLI episode 
T = total number of episode from February to April 2001 
The duration of FFLI episode should not be used to represent the number of days 
in productivity loss because the degree of sickness varies within the duration. In order 
to control for this characteristic, a set of weights was imputed on each day in the 
episode, depending on the degree of seriousness of the disease. According to the 
questionnaire design, the degree of sickness was classified into - mild, moderate and 
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severe. The weights that we use increase in the order of severity but the exact 
magnitudes are quite arbitrary. A tentative remedial recovered method is to conduct a 
sensitivity analysis over the results of the study to see whether the outcomes are robust 
against different sets of weights. In the benchmark case, one day of mild symptoms 
was estimated to affect 0.25 days of health; 0.5 days of loss on perfect health was 
assumed for moderate symptoms and severe symptoms led to 0.75 days of loss. 
In order to project the annual loss, the number of episodes from February to April 
was estimated in proportion to potential episodes for the whole year. According to table 
3.1, the cases during the three months, as reported by the Department of Health, 
accounted for 27% of the total episodes in 2001. Its reciprocal (3.75) multiplied with the 
total number of episodes in the three months gave the total number of episodes for an 
individual for the whole year. The product of number of days lost during the latest FFLI 
episode and the total number of episode in a year produced the annual EDPH loss per 
person. This was calculated for all individuals in all groups separately, without 
controlling for their demographic characteristics. 
The dollar loss from reduction in work capacity was estimated with the annual 
productivity loss in equation two. From the questionnaire, participants reported the 
number of days in which their work capacity were affected to different extents. In this 
study, one day of mild influence on employee's work was estimated to reduce 
productivity by 0.25 days; by the same reasoning, moderate and severe impact led to 0.5 
and 0.75 days lost respectively. Although the subjects reported that their illness did not 
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reduce their work capacity during some of the days, the investigator deemed that there 
would be a little influence on work capacity as long as the participants felt they were ill. 
So a day reported with no impact was assigned a value of 0.05 days lost in productivity. 
This multiplied with the daily salary of an individual gave the productivity loss per 
person during the latest FFLI episode. In projecting the figures to annual loss, the same 
method was used as in calculating EDPH loss. 
Equation 2 
Annual Productivity loss per person 
Productivity loss = ( N x 0.05 + Mi x 0.25 + M � x 0.5 + Se x 0.75 ) x Sa x 3.75 x T 
where N = number of days FFLI did not affect work capacity from the latest episode 
Mi = number of days FFLI mildly affect work capacity from the latest episode 
Mo = number of days FFLI moderately affect work capacity from the latest 
episode 
Se = number of days FFLI severely affect work capacity from the latest episode 
Sa = daily salary of the employee 
T = total number of episodes from February to April 2001 
Table 3.2 showed the average annual EDPH loss and productivity loss per person 
for the different groups and all related observations. Group C had the greatest EDPH 
loss per person per year due to FFLI (12.62 days), followed by Group B (9.51 days) and 
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Group A (6.9 days). For the whole sample, an individual lost 10.39 days of perfect 
health each year due to FFLI. Regarding productivity loss, Group C also incurred the 
highest economic cost at HK$9,369.20 a year. Group B lost HK$5,400.45 and Group A 
lost HK$2,291.48. On average, each employee lost HK$6,564.72 a year. 
These two equations standardized the FFLI impact on health and productivity, 
and FFLI impacts became comparable with these estimators. It reduced the influence of 
the varying severity of symptom duration for each episode. The estimators demonstrate 
that Group C suffered the greatest loss in terms of EDPH and productivity as a result of 
the illness. The higher loss seemed to be the combined effect of longer symptom 
duration and greater severity of the illness. It was probably a result of the poor working 
environment and its job nature. This has been explained in section 4.3. It is clear that 
congested work place conditions would lead to greater health loss and productivity loss 
for employees. In any situation, FFLI undermined employees' production efficiency. 
Productivity loss for Group C was four times that of Group A, but the EDPH loss 
of Group C was only two times their of Group A. Therefore pay was a factor in the 
estimated productivity loss. To eliminate the effect of salary, the following analysis 
focuses on EDPH loss only. 
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(5.2) Density estimation 
Before carrying out any statistical analysis, it was of interest to examine the 
probability distribution of the EDPH loss. The nonparametric kernel estimator was 
adopted to fully utilize the data. With this nonparametric approach, there would be 
fewer rigid assumptions about the observed data. Although it was assumed that the 
distribution had a probability density / , data were allowed to speak for themselves in 
determining the estimate of / more than for the case if f was constrained to fall under a 
given parametric family. Here the Gauss least square kernel estimation was used. 
The density distributions were not in a normal bell shape for all groups; rather 
they were clustered around zero to ten days of EDPH loss with long tails to the right, as 
can be seen in figures 1.1-1.4. The reason was that EDPH loss is positive in nature and 
some of the participants had no FFLI during the three-month flu season. This resulted in 
concentration of zero day health loss a year. However, some participants had many 
incidences during the flu season and the symptom durations were long which have 
given rise to the long tails. In general, distributions among the three groups are very 
similar; only their tails have lengthened with the risk factor. 
The above distribution resembles that of a log distribution. After deleting all the 
results of zero EDPH losses and taking log of the rest, it is shown in figures 2.1-2.4 that 
the rest of the observations approximated a normal distribution. They are almost in the 
same shape with a peak around one without the long tail as in the previous one. No 
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matter which analysis is used, the samples in the three groups have a similar EDPH loss 
distribution as shown in the figures. 
(5.3) Hypothesis testing 
One of the main concerns of this study has been to investigate whether there are 
significant differences in FFLI incidence and productivity loss between the employees 
in different working environments. The above statistics and calculations seem to 
support this hypothesis. The following reports on the hypothesis testing carried out to 
test the significance of these findings. 
Ordinary hypothesis testing assumes the population to be normally distributed. 
However, initial density estimation demonstrated that EDPH loss did not follow a 
normal distribution. It was impossible to find the confidence bound of the estimated 
variables. Also tests with an underlying normal distribution assumption were difficult to 
deploy since the means and standard deviations of the distributions were unknown. 
Thus, nonparametric tests were chosen for this testing. 
The distribution-free rank sum test by Wilcoxon, Mann and Whitney was used in 
this analysis. In addition the Kruskal-Wallis test, resembling the Mann-Whitney test but 
good for examining more than two populations, was used. These tests were relevant as 
an overall test for equality of population means or medians with identical and 
• 
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continuous distributions. The hypothesis underlying the tests is that a shift in location is 
referred to as an additive treatment effect and the null hypothesis is that the populations 
have the same medians. 
Difference in EDPH loss between the groups is statistically significant according 
to the Kruskal-Wallis test. The same results are also obtained in the Mann-Whitney test 
in two sample tests. The tests also showed that the differences between three groups or 
any two groups in productivity loss are significant. The p-values with a 95% confidence 
interval of the tests are shown in table 3.3. Only the test on productivity loss between 
Group B and Group C is statistically insignificant. 
This test indicates that the three samples are from different populations. The 
shifting effects that existed between the groups could be a result of different working 
environments. The varying results in terms of EDPH loss would be induced by the 
appearance of this risk factor. This matches previous findings that employees working 
in congested environment with poor ventilation suffered more from FFLI relative to 
those working in well-ventilated areas or offices. Those who work in well-ventilated 
environments would suffer the least health and productivity loss. 
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(5.4) Sensitivity analysis 
The estimator in the hypothesis tests was EDPH loss which was determined by 
the given parameters assigned. Hence the statistical results were subject to the influence 
of the chosen variables. The weighting variables were tested for their influence on 
equation 1 and 2 by 1 -way and 2-way sensitivity analyses. 
Duration variables with respect to the severity of symptoms were changed. Table 
3.4 listed the effect of these changes upon EDPH loss and productivity loss. The 
outcome is rational. When mild symptoms duration was assigned with a smaller effect 
(0.15 days loss), means and standard deviations of both EDPH loss and productivity 
loss became smaller. The estimators became bigger if the value of 0.85 days loss was 
assigned to severe symptom duration. If both variables were changed at the same time 
in the bivariate sensitivity analysis, the results became moderate. Hypothesis testing 
performed on these changed equations showed that all of them are significant 
statistically. P-values with 95% confidence interval are shown in table 3.4. 
Neither EDPH loss nor productivity loss is sensitive to changes in duration 
variables, and hypothesis testing on EDPH loss yields the same outcomes as in the 
baseline analysis. This confirms that the established equations are robust as all groups 
were distinct in all scenarios. No variable exhibits sensitivity on the estimators. 
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(5.5) Regression analysis 
An ordinary least square (OLS) regression was conducted to quantify the 
relationships between estimated EDPH loss and an individual's background information 
which included sex, age, smoking experiences, hours spent on physical exercise per 
week, nasal and lung diseases, annual salary and the groups they belong to. EDPH loss 
was regressed on the above variables. In OLS regression, normal error is assumed 
which means that dependent variables would have a normal distribution. Again density 
estimation demonstrated a non-normal distribution of EDPH loss and its logarithm 
displayed a bell shaped distribution. Therefore log EDPH loss was used in this 
regression. 
A total of 1,066 observations were used because those having zero EDPH losses 
were excluded. Observations in group A, B and C became 136, 457 and 476 
respectively. All the independent variables were dummies due to the questionnaire 
design. Therefore, sex was defined as one for male and zero for female. As no subject 
was under 18 years old and none had an annual income smaller than HK$50,000, these 
categories were deleted. Age and salary were regressed in dummy form. For example, a 
subject aged between 18 and 25 would have an age dummy of one in this category and 
zero for the other age categories. The same method was applied to salary and physical 
exercise. For smoking experience, the dummy of one was assigned to the answer that 
the subject chose and the others were assigned zero. Those who had nasal diseases 
would have dummy for one and no for zero. The variable of lung diseases was treated 
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the same way as nasal disease. In the questionnaire, subjects checked the position they 
belonged to and we had divided the six positions into three groups at the beginning of 
the analysis. So in the regression of all staff, dummy one was assigned to the class they 
belonged to. 
As is shown in table 3.5, the underlying variables can not explain the estimator 
log EDPH loss as the R-squares for all cases are less than 10%. It could be the result of 
using dummy variables in regression instead of raw data. Since log EDPH loss are 
continuous variables, it would not be suitable to regress them with dummy independent 
variables. However we could still compare the signs of the coefficients and their 
consistency across the groups. 
Studies have shown that gender and age influence the incidence and impact of 
FFLI among patients. In all the regression equation, the variable "male" shows a 
consistent negative sign, meaning "male" would have lower cost from FFLI. In the best 
regression scenarios, ages are insignificant in the variation of loss in all sub-samples. 
Though the age group "26 to 30" years shows significance in Group A's model, no 
meaningful result can be concluded because the other age options are insignificant for 
comparison. Therefore the present outcome does not seem to agree all common wisdom. 
Also it was expected that people with underlying nasal or lung diseases would 
entail a higher incidence of FFLI and more severe impact. In Group C and all staff 
analyses, they reveal that nasal illness has contributed significantly higher losses from 
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FFLI. But in other cases, the p-values of these underlying diseases variables are so high 
that statistically they do not show any significant effect log EDPH loss. 
A general perception is that, spending more time on physical exercise would 
build up body resistance against FFLI and these people would have a lower incidence 
and severity. Participants spending less then one hour in physical exercise result in less 
loss as indicated in Group A, C and all staff analysis. However, this variable exhibits a 
positive sign in Group B. Thus, the regression analysis is not in agreement with this 
perception. 
All regression cases show no significant correlation between smoking experience 
and EDPH loss; and annual income and EDPH loss. 
As mentioned above, when considering all the participants (n = 1,066), there is an 
apparent gender effect as greater loss was experienced by female employees (p-value = 
0.001). However, this effect does not appear in either Group A or B regressions since 
this variable is not statistically significant. So the effect in the whole pool was mainly 
induced by Group C. In this sense, it should be concluded that there is no gender effect 
in the present study and no relationship has been found between EDPH loss and 
demographic characteristics. 
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(5.6) Long Haul flights and FFLI 
According to table 3.6, many FFLI during February to April 2001 had developed 
in Europe and North America among Group C. Statistical analysis was conducted to test 
this observation. Firstly, fight schedules during this period were used^^. The proportion 
of flights to Europe and North America in terms of total flights during this period was 
tested against the proportion of FFLI episodes developed in these two regions. The null 
hypothesis is defined as no difference between the two proportions denoting that more 
number of episodes after a trip to Europe and North America is normal and no risk 
factor is found. The alternative is that risk factors contribute to the observed result. 
Statistical tests have confirmed that significantly more incidences occurred after long 
trips, after controlling for the number of trips'^ to various destinations (z-value = 12.51). 
Therefore, another risk factor has been found to contribute to a higher incidence 
for this group. The second risk factor is attributed to the temperature gap between Hong 
Kong and Europe/North America during the period. Moreover, working for longer 
hours between rest periods also contribute to a higher incidence. After a long trip, 
fatigue would weaken a person's health and lead to lower resistance. This could 
explain why shorter flights would induce lower incidences. 
15 Source: South China Morning Post 
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(5.7) Company profit 
From the employers' perspective, employees play a main role in its production 
process. If they suffer from any illness leading to loss of productivity or miss work days, 
production efficiency will be reduced. Medical cost is one of the costs that a company 
has to bear as a result of employees' sickness, but the related indirect costs to the 
company might be even higher. Since FFLI is one of the most common diseases among 
humans, employees suffering from this illness will certainly bring about serious loss. 
Therefore it is important to identify the associated indirect costs thus incurred to the 
employer. 
Firstly, taking into account the total staff in this airline corporation, we estimated 
its weighted average EDPH loss and productivity loss. The projected annual EDPH loss 
was 11.05 days and annual productivity loss was HK$ 7,394.35 per person. Compared 
to figures in section 5.1, the weighted average losses are higher because Group C, the 
group with higher cost impact, dominates the total staff population. 
From the company's annual report, the calculated average annual profit in the 
past 10 years was HK$3,279 million and the average annual staff expenses were 
HK$7,572 million; thus staff expenses were HK$20.75 million per day. By multiplying 
the number of day loss with daily staff expenses, we have found that there was an 
annual loss of HK$229.23 million as a result of FFLI. Based on the company's average 
profit, there was a 6.53% profit loss associated with FFLI. Extending the analysis, the 
5 8 
amount of loss could be used in other ways that could generate more profit. In this sense, 
the actual loss to the company might even be larger than this amount. The calculations 
are shown in table 3.7. 
(5.8) Society loss - GDP 
It has been reported in the literature that indirect costs associated with FFLI were 
a lot greater than those incurred in healthcare costs utilization. Thus it is important to 
explore the indirect costs thus caused to society. The present study measures worker's 
productivity loss which affects society output in terms of Gross Domestic Product 
(GDP). 
Here are the assumptions. 
GDP (total income) of an economy is determined by capital and labour only. 
With the capital formation fixed in the short run, economic output would change in 
proportion to labour forces. If the latter is affected by illness, output would drop in 
proportion to the number of working days lost. As this study has shown that the gender 
effect does not exist, it will not be considered here. 
Utilizing the results from the above sections, we projected the indirect costs 
brought about by FFLI to the entire society. In general, the majority of the working 
population in Hong Kong works in well-ventilated or typical office environments. Since 
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the average loss to all staff comprised data from Group C whose work conditions are 
not typical of the average workplace in Hong Kong, calculation for the general public 
has excluded data from Group C to prevent upward bias. So after taking the average of 
the EDPH loss from Group A and B, we found that each person lost 8.8 days a year and 
this was used for calculation for societal loss. The day loss in a year implied 2.41% of 
manpower would have been lost from the illness. Given the Hong Kong GDP in 2000 
was HK$ 1,267,175 million, the potential GDP, without loss due to FFLI, would have 
amounted to HK$ 1,298,468 million. Therefore FFLI would induce an economic loss of 
HK$31,293 million per year to the Hong Kong society. The calculations are shown in 
table 3.8. 
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CHAPTER SIX DISCUSSION 
The response rate in the present study is similar to those in other questionnaire 
survey studies conducted in Hong Kong^^ . Some of the surveys had the participants' 
administer questionnaires themselves and some were conducted by interview. Their 
response rates ranged from 10% to 33%. In fact, working hours and job natures in this 
company had affected the number of respondents for the present study. Due to the job 
nature of aircrews, many of them were out of town or missed the questionnaire. 
Consequently, the study only recruited 20%.. Prolonging the survey period would 
improve the response, which will in turn increase the reliability of the results. 
It is generally difficult to distinguish between FFLI and other respiratory 
pathogens as identical symptoms appear for these two types of diseases. Moreover, no 
test was performed to confirm participants' infection with flu viruses in this study. 
Respiratory illnesses may be treated as FFLI by employees and included in the survey. 
Such indeterminacy could have inflated the costs of FFLI relative to the 'true' cost. 
Moreover, there was no report on the participants' vaccination histories. Without such 
information, the incidence rate could have led to an upward bias. This would exaggerate 
the estimated FFLI indirect cost. 
16 Refer to Yeung CK et al.(2002),Johnston JM et al. (2002), Akhtor S. and Lee JS. (2002), N g KK et al. 
(2000), 
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Given the format of a questionnaire survey, responses could be subjective. As 
answers relating to the severity of symptoms and the degrees of impact of the illness 
depended a lot on participants' judgments, this could have affected the measurements 
for EDPH loss and productivity loss. For instances, there could have been FFLI recall 
bias. Subjects were asked to provide detailed information about their episodes over the 
preceding three months and the latest illnesses. It was especially difficult for 
participants to recall the exact symptom's duration or the length and extent of their 
work performance impairment. Hence, data accuracy is one variable that could have 
biased the results. Nevertheless, as there were clear guidelines accompanied by Chinese 
translations included in the questionnaire, and interviewers also explained the questions 
comprehensively, the degree of subjectivity would have been reduced to a minimum. 
The incidence of short-term absences from work depends on the absentees' 
professions, the type the organizations and the production process. Although work 
replacement during employees' absences were not directly measured in questionnaire 
and no information was obtained for the company's human resources department, it was 
acknowledged that there were direct substitutions for aircrew positions in case of illness. 
. Standby cabin crew and cockpit crew would take up the work of the absentees' in order 
to maintain service continuity. In such case, the overall cost for the company is likely to 
be lower than the cost for the individuals. The estimated productivity loss in this group 
would have been overestimated for the company. However, little information could be 
obtained to adjust this miscalculation. 
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Besides, employees' loss of productivity was not confined to missed work days. The 
questionnaire in this study asked about the impact of FFLI on employees' work capacity. 
The results indicate that mild, moderate and severe effects were experienced depending 
on the severity of one's illness. This is consistent with Keech et al. (1998)'s findings 
that a premature return to work before the alleviation of all symptoms can impair 
effectiveness and affect productivity. 
On average, employees with FFLI only reported 1.03 days of sick leave for the 
most recent episode. The figure is relatively low compared to Keech et al. (1998)'s 
results (2.8 days) obtained in a well-defined FFLI season. The present findings are 
consistent with the view that employees in Hong Kong tend not to stay at home to treat 
their symptoms and are rarely admitted to hospital. Moreover, it also attributes to the 
characteristics of the employee profession. Due to their job nature, aircrew, the second 
largest group in the present study, would have different propensities to take sick leave. 
In between each trip, there are a few days off for flight attendants and pilots. Therefore, 
even if they were ill they would rather take a rest after their travels and not ask for leave. 
Furthermore, staff are required to present the company doctor's memo to requesting 
leave with pay. Since it might be difficult to obtain an approval from the doctors for 
sick leave, the actual days missed for FFLI could have been underestimated. Low 
incidence of sick leave may have been a consequence of the above factors and it is 
difficult to identify the main contributor. In conclusion, it is clear that less sick leave 
may prolong an employee's FFLI duration and lengthen their recovery period. This has 
a direct effect on the calculation of EDPH and productivity loss. 
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According to practicing medical doctors, a number of risk factors have been 
identified as generating a higher FFLI incidence rate. Such factors were incorporated in 
the questionnaire as gender, age, smoking experience, chronic illness and time spent on 
physical exercise. Regression analysis suggests that the results of the current study are 
not explained by differences in these demographic factors. Subject to the nature of the 
data, the present regression analysis may have suffered from some deficiencies which 
have led to the contradictory results relative to common wisdom. Also analyses on sub-
samples were using different dependent variables and this precluded a meaningful 
comparison. As a result, no clear relationship has been revealed in this analysis. On the 
other hand, the hypothesis testing shows that poor workplace condition is the only risk 
factor identified the present study and points to the importance of working environment 
as an independent risk factor for FFLI. 
The present study also confirms that employees in Hong Kong generally visited 
western doctors more often than using other treatment methods. Because of the tradition 
in Chinese culture and evidence supporting the effectiveness of Chinese medicine, some 
of the participants also used Chinese herbal medicine to treat FFLI. However, more 
visits to Chinese practitioners would have been made if there had been medical 
insurance coverage for these treatments as well. 
FFLI induced a projected HK$31,293 million indirect cost to society as estimated 
in the current study, and it was far more than that reported in Fitzner et al.'s (2001) two-
year study conducted on all Hong Kong people. The big difference can be attributed to a 
6 4 
difference in research design and methodology. In the present study, societal loss was 
estimated from employees of a single company. The sample may not be representative 
of the Hong Kong working population and consequently, bias would exist in the 
calculations. Nevertheless, the three months FFLI period and the most recent episode 
might not incur similar impact on individuals. Therefore, year cost would be 
inaccurately approximated. Also wage loss from work capacity reduction during illness 
was utilized as the proxy for indirect cost, whereas Fitzner et al. (2001) included 
absence from work and school in his study. 
In fact, the two studies had different perspectives and their results might not be 
comparable. Future studies from the society's point of view should include this 
productivity cost to achieve a better evaluation. 
For the company under study, FFLI associated annual productivity loss is 
estimated to be at HK$7,394.35 per member of staff. Based on the vaccination 
effectiveness rate from recent studies 口 (33%-80%), vaccination could avert 
HK$2,440.14 to HK$5,915.48 indirect cost of production losses for each employee. 
Thus it would be beneficial to the company if each vaccination costs less than the 
minimum gain. 
From an economic perspective, employees in well-ventilated working conditions 
would save HK$756.19 to HK$1,833.18 for each vaccinee. It would reduce productivity 
17 Maarten J. Postma et al. (2002) 
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losses for each office employee to about HK$ 1,782.15 to HK$4,320.36. The largest cost 
reduction would be among the employees working in poor environments (ranging from 
HK$3,091.84 toHK$7,495.36 per person). 
As the benefit of vaccination varies among working adults and depends on the 
working environment, the authorities should take this variable into account when 
planning for a FFLI vaccination program in Hong Kong. The present results suggest 
that vaccination for workers working in inferior environments is the most cost-effective. 
In the future, a pilot questionnaire is recommended for this kind of survey study 
to establish the likely response rate and sample characteristics. Samples should be 
distinguished between voluntary return and self-administration to correct for a possible 
selection bias where questionnaires are more likely to be completed by people having 
suffered from FFLI. In order to reduce recall bias, questionnaire could be sent before 
the target survey period for participants to record their sickness details. Quality 
assurance tests could be conducted on the questionnaires returned to improve the 
accuracy. 
6 6 
CHAPTER SEVEN CONCLUSION 
With a congested and polluted environment, the indirect cost stemming from 
FFLI was substantial in Hong Kong. In this study, the incidence rate was not higher 
than that of other countries and discernibly Hong Kong required less sick leave. 
Working adults' normal activities and work performances deteriorated because of the 
illness. Statistical tests confirm that workers in congested workplaces with poor 
ventilation would induce more health and productivity losses. For companies with a 
distinctive production process, such as the company in this study, a risk factor may exist 
that would cost higher economic losses. Consequently, employers should provide 
proper preventive measures against FFLI for these parties. Hong Kong society also lost 
2.41% manpower a year, amounting to HK$31,293million. In 2000, the Hong Kong 
1 n 
government spent about the same amount on healthcare expenditure . 
The present study was the first of its kind conducted in Hong Kong and only a 
typical picture was sketched. A study on the productivity loss caused by FFLI among 
working adults is needed to facilitate the introduction of preventive schemes. The 
present research defined and prioritized the burden of FFLI and heightened the public 
awareness of the problem among the non-medical professions. The public should be 
cultivated with accurate information about FFLI and the preventive measures. 
18 Sources: Hong Kong Census and Statistic Department 
Expenditure on health was HK$ 31.9 billion 
6 7 
Authorities should also allocate resources more effectively and develop medicines to 
protect the public afainst it. 
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Tables 
Table A Summary of Literature Review 
Study Type of study Population (working adults) Perspective Study design Case definition Attack rate 
Nichol etal contro l l ed~~ aged 18-64 years society randomized sore throat with fever or 69% 
(1995) trial double-blind trial a cough lasting >24 (observed) 
in 1 flu season hours 
Kumpulainen controlled aged 18-62 years society non-randomized serologically confirmed 1.6% 
and Makela trial non-placebo trial flu (observed) 
(1997) in 1 flu season 
Campbel controlled median age 45 years employer non-randomized respiratory illness of 49% 
and Rumley trial non-placebo trial more than 2 days' (observed) 
(1997) in 1 flu season duration with 1 or more 
systemic symptoms and 
respiratory tract 
symptoms 
Bridges et al controlled aged 18-64 years society randomized 1) feverishness or 5% 
(2000) trial double-blind trial temperature >=37.7°C (estimated) 
in 2 flu season (100°F) plus cough or 
sore throat 
2)URI as sore throat plus 
cough, feverishness or 
temperature >=31.TC 
(IQO'F) 
Buckel et al. stimulation aged 18 to > 65 in a company employer case study with none 10% 
(1999) cost data based on 
published data and 
company 
information 
Nichol stimulation health working adults between society Monte Carlo none 5-15% 
(2001) 18 and 64 years simulation with 
data derived from 
the published 
literature 
Muennig s t imula t ion~ all health adults aged 15-65 society decision-analysis fever or temperature < 10% 
and Khan years residing in U.S. in 1997 using published > = 3 7 � C plus cough or 
(2001) data sore throat 
Study I Efficacy rate [Direct cost per case I Indirect cost outcomes Cost-benefit 
Nichol etal . 25-44% US$166.82 (1995value) US$485.68 fewer episode o f U R l , net benefit 
(1995) (observed) (1995value) days of sick leave and US$46.85 
physician consultations (1995value) 
Kumpulainen 65% ( o b s e r v e d ) ~ US$3.70 (1997value) US$16.42 no infections in vaccinated net cost 
and Makela (1997value) group US$106.59 
(1997) (1997value) 
Campbel 24-59% US$45-47 (1997value) US$30.53 compared with net benefit 
and Rumley (observed) (1997value) nonvaccinated group, US$2.58 
(1997) vaccinee had fewer (1997value) 
episode and missed work 
days 
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Bridges et al. |50%in 97-98 IUS$106.17 (2000value) |US$264.49 197-98 more episode, lost 197-98 net cost 
(2000) 86% in 98-99 (2000value) workdays and US$65.59 
physician consultations (2000value) 
than placebo group 98-99 net cost 
98-99 less episode，lost US$11.17 
work days and physician (2000value) 
consultations than placebo 
group 
Buckel et al. 70-89% (estimated US$8 for low morbidity 1 day absent in low fewer ILI incidence and net benefit 
(1999) with age and US$50 for moderate morbidity work lost US$2.47 
illness severity morbidity 3-4 days absent in (1997value) 
prevented) US$160fbr high morbidity moderate morbidity 




Nichol 35% in poor US$80-US$ 123 (1998value) no clearly stated fewer missed work days, net benefit 
(2001) match scenario physician visit， US$13.66 
75% in good hospitalization and death (I998value) 
match scenario rate 
Muennig no clearly s t a t e d ~ US$64.39 (1997value) no clearly stated fewer ILI symptoms net benefit 
and Khan compared with using US$ 13 
(2001) supportive care (1997value) 
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Table 1.1 Background information of participants 
Group A Group B Group C All Staff 
Average age 26.1 33.9 30.6 3.3 
Age 18-25 ^ iWo 
25-30 35% 30% 31% 29% 
31-35 13% 24% 24% 22% 
36-40 4% 17% 13% 13% 
41-45 0% 12% 5% 7% 
45-50 0% 6% 2% 6% 
>50 0% 3% 1% 2% 
n = 340 n = 911 n = 900 n = 2,151 
Sex Male ^ 43% iWo ^ ^ 
Female 76% 57% 77% 68% 
n = 344 n = 922 n = 905 n = 2,171 
Smoking Current smoker 17% \\% 15% 14% 
experience Ex-smoker 7% 7% 14% 10% 
Never smoke 76% 87% 71% 76% 
n = 275 n = 764 n = 812 n= 1,851 
Underlying Nasal disease ^ 15% \Wo i W o ^ 
illness Lung disease 6% 5% 3% 5% 
n = 344 n = 923 n = 906 n = 2,173 
Physical <1 hour m^o ffVo 
exercise 1-2 hours 26% 28% 30% 29% 
(time spend 2-6 hours 17% 28% 23% 24% 
per week) >6 hours 4% 5% 10% 7% 
n = 343 n = 922 n = 905 n = 2,170 
Annual <50,000 Wo 0% Wo 0 % ^ 
Income 50,001 - 100,000 8% 5% 7% 6% 
(HK$) 100,001 - 200,000 58% 34% 40% 41% 
200,001 - 400,000 33% 44% 35% 39% 
400,001 - 800,000 0% 13% 11% 10% 
800,001 - 1,600,000 1% 3% 5% 3% 
>1,600,000 0% 0% 2% 1% 
n = 344 n = 922 n = 903 n = 2,132 
— ”• i. I'lT. •••'.：.  ,：： — • .J ： .., - • ,； , •；•—,—J •“丨丨 I .1 •丨  I •• • • ••• — 
n = the number of respondents 
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Table 1.2 Incidence of FFLI from February to April 2001 by category 
Group A Group B Group C All Staff 
Number of FFLI 
Sum of episodes 300 1012 991 2303 
Episode per person 0.87 1.10 1.09 1.06 
n % n % n % n % 
Subjects with FFLI " T ^ 5 4 ^ ^ ^ W 
Incidences of FFLI 
Required days off no 204 68 624 62 636 64 1,464 64 
yes 96 32 388 38 355 36 839 36 
Affected normal level no 154 51 384 38 440 44 978 42 
of activity at work yes 146 49 628 62 551 56 1,325 58 
Needed bed rest no 152 51 503 50 455 46 1,110 48 
yes 148 49 509 50 536 54 1,193 52 
Affected colleague no 259 86 751 74 796 80 1,806 78 
yes 41 14 261 26 195 20 497 22 
Affected family no 241 80 704 70 691 70 1,636 71 
yes 59 20 308 30 300 30 667 29 
Number o f respondents in each group 
Group A - 344 
Group B - 922 
Group C - 906 
T o t a l - 2 , 1 7 2 
Table 1.3 Days missed due to FFLI from February to April 2001 by category 
Group A Group B Group C All staff 
Days n % n % n % n % 
0 105 5 8 ^ 4 6 m 4 6 ^ W 
0.5 - < 3 72 40 259 46 155 31 486 39 
3 - < 7 4 2 38 7 98 19 140 11 
7 - < 14 0 0 5 1 18 4 23 2 
> 14 1 1 2 0 4 1 7 1 
Number o f respondents in each group 
Group A - 3 4 4 
Group B - 922 
Group C - 906 
T o t a l - 2 , 1 7 2 
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Table 2.1 Symptoms duration by the degree of severity of the most recent FFLI 
Group A Group B Group C All staff 
day % day % day % day % 
Mild 8 7 1 . 5 ^ 2 4 4 3 . 0 5 0 2 8 8 7 . 5 4 7 6 2 0 2 . 0 W 
Moderate 614.0 37 1706.5 35 2106.0 35 4426.5 35 
Sever 185.0 11 718.0 15 1096.0 18 1999.0 16 
Total days 1670.50 4867.50 6089.50 12627.5 
Total episodes 344 923 906 2173 
Duration/episode 4.86 5.27 6.72 5.81 
Episode/person/year 3.26 4.13 4.09 3.98 
Number of respondents in each group 
Group A - 344 
Group B - 922 
Group C - 906 
T o t a l - 2 , 1 7 2 
Table 2.2 Number of days affecting work capacity by the degree of illness severity 
Group A Group B Group C All staff 
day % day % day % day % 
Not affected 648 39 1878 38 2277 37 4802 38 
Mild 608 36 1493 30 1603 26 3703 29 
Moderate 278 17 996 20 1191 19 2465 19 
Sever 137 8 563 11 1039 17 1739 14 
Number of respondents in each group 
Group A - 344 
Group B - 922 
Group C - 906 
T o t a l - 2 , 1 7 2 
Table 2.3 Impact on daily activities and work capacity by the most recent FFLI 
episode 
Daily activity affected Work capacity affected 
Onset 5-7days later onset 5-7days later 
n % n % n % n % 
Not affected " 3 7 7 1 7 1 2 2 3 5 6 2\ 
Mildly 1038 48 505 23 880 41 454 21 
Moderately 570 26 322 15 549 25 299 14 
Severely 182 8 117 5 276 13 149 7 
Number o f respondents: 2 ,167 
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Table 2.4 Symptoms of the most recent FFLI episode 
Onset 5-7 days 
n % n % 
Mild fever 945 48 147 8 ^ 
High fever 132 8 66 5 
Chills 626 36 135 9 
Mild headache 1271 62 297 19 
Severe headache 295 20 135 10 
General aches and pains 1133 61 320 21 
Fatigue and weakness 1399 74 548 35 
Extreme exhaustion 365 24 208 14 
Sneezing 1181 61 300 20 
Stuffy nose 1181 60 444 28 
Runny nose 1195 59 439 26 
Whitish nasal discharge 669 36 262 15 
Greenish, yellowish nasal discharge 311 18 279 19 
Chest discomfort 228 14 113 9 
Sore throat 1487 75 475 31 
Cough 1052 54 626 39 
Whitish sputum 351 20 186 12 
Greenish, yellowish sputum 358 23 294 21 
Ear block 11 1 9 1 
Others 57 3 32 2 
Number o f respondents: 2,172 
Table 2.5 Types of treatment received of the most recent FFLI episode 
n o/o 
No treatment 164 8 
Self-treatment with over-the-counter drugs 470 22 
Self-treatment with vitamin supplements 249 11 
Self-treatment with Chinese herbal medicines 87 4 
Self-treatment with Chinese proprietary medicine 40 2 
Visit western doctors 1568 72 
Visit Chinese medicine practitioners 127 6 
Other treatment methods 15 1 
Number o f respondents: 2,169 
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Table 2.6 Reasons of no treatments of the most recent FFLI episode 
n o/o 
No need, illness would recover sooner or later 126 77 
FFLI could not be cured by treatment 19 12 
No time to go for treatment 26 16 
Treatments are too expensive 1 1 
Treatments are not effective 10 6 
Others 24 15 
Number o f respondents: 164 
Table 2.7 Reasons for treatments of the most recent FFLI episode 
n o/o 
Could not stand the symptoms 993 50 
Hoped to recover sooner 1563 78 
To prevent complications 388 19 
To treat complications 126 6 
To prevent infecting others 458 23 
Others 48 02 
Number o f respondents: 2,005 
Table 2.8 Sick leaves of the most recent FFLI episode by category 
Sick leave 
Total Mean 
Group A o S 
Group B 759 0.82 
Group C 1301.5 1.44 
All staff 2240.5 1.03 
Number o f respondents in each group 
Group A - 344 
Group B - 923 
Group C - 905 
T o t a l - 2 , 1 7 2 
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Table 2.9 Hospitalization of the most recent FFLI episode 
Reason Number of episode 




Number o f respondents: 2,063 
Table 3.1FIu surveillance weekly and monthly consultation rate of FFLI reported 
by General Out-patient Clinics (GOPC) and General Practitioners (GP) ^ 
Rate 
(per 1 000 consultations) 
Month GOPC GP 
January 5.4 41.3 
February 5.2 50.9 
March 6.6 52.7 
April 4.9 46.8 
May 6.2 55.2 
June 6 52 
July 5.3 48.4 
August 4.6 44 
September 3.1 42.2 
October 3.5 48.4 
November 3.6 42.4 
December 3 44.2 
Table 3.2 EDPH loss and Productivity loss by category 
Annual EDPH loss per person Annual Productivity loss per person 
mean (s.d.) mean (s.d.) HK$ 
Group A 6.90 (13.96) 2,291.48 (5,338.78) 
Group B 9.51 (21.28) 5,400.45 (16,914.59) 
Group C 12.62 (21.79) 9,369.20 (30,215.65) 
AH Staff 10.39 (20.62) 6,564.72 (22,652.55) 
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Table 3.3 Kruskal-Wallis Test and Mann-Whitney Test results table 
(test against 95% confidence interval) 
EDPH loss Productivity loss 
p - value p - value 
Mann-Whitney Test 
Group A vs Group B 0.005 0.000 
Group B vs Group C 0.013 0.176 
Group A vs Group C 0.000 0.000 
Kruskal-Wallis Test 
All Groups 0.000 0.000 
Table 3.4 Sensitivity analysis 
Value Mann-Whitney Test Kruskal-Wall is Test 
Group A Group B Group A 
vs vs vs 
mean (s.d.) Group B Group C Group C All Groups 
m m m (P<) 
Ml X 0.25 + M2 X 0.5 + M3 x 0.75* 
E D P H loss 10 .39(20 .62) 0.005 0.013 0.000 0.000 
Productivity loss (HK$) 6,564.72 (22,652.55) 0.000 0.176 0.000 0.000 
Ml X 0.15 + M2 X 0.5 + M3 x 0.75 
E D P H loss 9.21 (18.95) 0.005 0.015 0.000 0.000 
Productivity loss (HK$) 5,985.26 (21,728.97) 0.000 0.126 0.000 0.000 
Ml X 0.15 + M2 X 0.5 + M3 x 0.85 
EDPH loss 9.61 (19.92) 0.005 0.016 0.000 0.000 
Productivity loss (HK$) 6,340.79 (23,562.38) 0.000 0.129 0.000 0.000 
Ml X 0.25 + M2 X 0.5 + M3 x 0.85 
E D P H loss 10 .79(21 .56) 0.005 0.015 0.000 0.000 
Productivity loss (HK$) 6,920.25 (24,449.26) 0.000 0.164 0.000 0.000 
• B a s e case 
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Table 3.5 Regression Results 
Group A 
log edph = 1.203 - 0.106 M + 0.185 a28 + 0.213 a32 - 0.230 si50 - 0.385 s300 
-0.165 hrl - 0.129 hr4 
R-Sq=9.7% R-Sq(adj)=4.8% 
Group B 
log edph = 0.902 - 0.0764 M + 0.0515 hrl +0.110 hr4 
R-sq=1.3% R-Sq (adj)=0.6% 
Group C 
log edph = 1.297 - 0.160 M + 0.145 nasal - 0.188 hrl - 0.211 hrl .5 - 0.0989 hr4 
R-Sq=4.6% R-Sq (adj)=3.6% 
All Staff 
log edph = 0.948 + 0.237 Aircrew + 0.0512 Ground-0.101 M + 0.0763 nasal 
-0.0701 hrl -0.0751 hrl.5 
R-Sq=7.0% R-Sq (adj)=6.5% 
Group A Group B Group C All Staff 
Predictor Coefficient P-value Coefficient P-value Coefficient P-value Coefficient P-value 
Constant 1.203 0.000 0.902 0.000 1.297 0.000 0.948 0.000 
Aircrew - - - - - - 0.237* 0.000 
Ground - - - - - - 0.051 0.243 
Male -0.106 0.245 -0.076 0.097 -0.160* 0.001 -0.102* 0.001 
Age 
< 1 8 - - - - - - - -
18-25 - - - - - - - -
26-30 0.185* 0.023 - - - - - -
31-35 0.213 0.110 - - - - - -
36-40 - - - - - - - -
41-45 - - - - - - - -
46-50 - - - - - - - -
> 5 0 - - - - - - - -
Nasal disease - 0.145* 0.008 0.076* 0.035 
Physical exercise 
< 1 hour -0.165* 0.049 0.052 0.329 -0.188* 0.016 -0.070* 0.039 
1-2 hours - -0.211* 0.007 -0.075* 0.037 
2-6 hours -0 .129 0.256 0.110 0.059 -0.099 0.201 - -
•Signif icant at 95% confidence level 
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Table 3.6 Number of flight to different cities and FFLI episodes from February to 
April 2001 
February March April Total 
Flight FFLI Flight FFLI Flight FFLI Flight FFLI 
S.E. Asia 220 3 ^ 16 ^ 30 714 49 
Japan, Korea, Taiwan 250 5 257 5 276 14 783 24 
New Zealand 63 3 67 5 66 19 196 27 
N. America 65 9 71 17 72 33 208 59 
Mid East 18 0 24 2 28 3 70 5 
S. Africa 3 0 4 0 4 0 11 0 
Europe 72 16 80 15 78 43 230* 74* 
* Number of respondents 905 
Table 3.7 Calculation of FFLI impact on company loss 
Total number of staff Calculation of company annual loss 
Group A Group B Group C Average annual profit HK$3,279 million 
1,500 2,500 6,400 Average annual staff expense HK$7,572 million 
Average daily staff expense HK$20.75 million 
In proportion to all staff based in H.K. Annual loss from FFLI HK$229.23 million 
Annual EDPH loss i T ^ (11.05 x20.745) 
Annual Productivity loss HK$7,394.35 % loss on profit w FFLI 6.53%* 
Table 3.8 Calculation ofFFLI impact on the Hong Kong GDP 
Society loss 
Average EDPH loss s J * 
% of human power loss per year 2.41% = (8.8/365) 
Y (1-2.41%) = Y, 
2000 current GDP (Y') HK$ 1,267,175 million 
Potential GDP (Y) HK$ 1,298,468 million* 
Loss HK$31,293 million* 
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Figures 
Figure 1.1 Group A Equivalent Days of Perfect Health (EDPH) Loss Density Function 
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Figure 1.2 Group B Equivalent Days of Perfect Health (EDPH) Loss Density Function 
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Figure 1.3 Group C Equivalent Days of Perfect Health (EDPH) Loss Density Function 
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Appendix 
Questionnaire Survey on Flu and Flu-Like Illness 
Thank you very much for participating in this survey, which is conducted by a group of 
medical researchers from the Chinese University of Hong Kong. Knowing your 
experience with flu and flu-like illness will be of immense value towards our 
understanding of the incidence and impact of these illnesses on Hong Kong people. In 
this anonymous survey, the information you provide will be treated in the strictest 
confidence. For enquiries, please contact Prof. Kenneth Lee on email address 
kclee@cuhk.edu.hk. 
The common symptoms of flu(感冒）or flu-like illness(感冒般的症狀）are: 
• Sore throat(喉嚨痛）• Sneezing(打噴嚏）• Runny nose(流鼻水）• Stuffy 
nose(鼻塞） 
• Cough(咳嗽）• General aches and pains(—般疼痛）• Fatigue(疲勞）• 
Fever(發燒） 
In the past three months (Feb 1，2001 to April 30，2001), have you ever had one or 
more episodes of flu or flu-like illness? (please insert in the appropriate box) 
口 Yes, please proceed to Parts I, II & III 
口 No, please proceed to Parts II & III 
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Part I: Flu or flu-like illness in the past 3 months 
1. Number of episodes 
Feb, 2001 March, 2001 April, 2001 
Total number ot episodes ‘ 
Number ot episodes ot tlu or tlu-like illness that: 
(1) Required days off 
~ ( 2 ) Affected normal level of activity at work 
~ ( 3 ) Needed bed rest 
(4) Also affected your colleagues 
~~(5) Also affected your family members 
2. Approximate total number of days for which you could not report for work 
because of flu or flu-like illness between Feb 1，2001 and April 30，2001. (phase insert 
• in the appropriate box) 
n Oday 
n 1 to 3 days 
n 4 to 7 days 
n 8 to 14 days 
n >14 days, please specify if possible : 
Part II. Most recent episode of flu or flu-like illness with moderate to 
severe symptoms 
We would like to know more about your most recent episode of flu or flu-like illness 
with moderate to severe symptoms (e.g. affecting your normal activities and daily living 
or requiring bed rest). 
1. When did this occur? 
Approximate date: (month) of (year). 
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2. What symptoms did your have? (please insert • in M appropriate boxes) 
At the onset: 5 to 7 days later: 
Mild fever (輕微發燒) 
High fever (發高燒) 
Chills (發冷) 
Mild headache (輕微頭痛) 
Severe headache (嚴重頭痛) 
General aches and pains (一般疼痛) 
Fatigue and weakness (疲勞和虛弱) 
Extreme exhaustion (極度疲憊) 
Sneezing (打噴噴)‘ 
Stuffy nose (鼻塞) 
Runny nose (流鼻水) 
Whitish nasal discharge (透明鼻塞分泌物) 
Greenish, yellowish nasal discharge 
(綠黃g鼻塞分泌物） 
Chest discomfort (胸咅不適) 
Sore throat (喉 l | |痛)‘ 
Cough(咳嗽) “ 
Whitish sputum (白痰) 
Greenish, yellowish sputum (綠黃痰) 
Others, please specity : 
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3. What treatments did you receive? (please insert • in M appropriate boxes) 
No treatment I Go to 3 ( i ) ~ 
Self-treatment with over-the-counter drugs for colds (西成藥） Cio to 3( i i}~ 
Self-treatment with vitamin supplements (維他命) Go to 3(ii) 
Self-treatment with Chinese herbal medicines (中藥) Go to 3(ii) 
Self-treatment with Chinese proprietary medicine (中成藥) Go to 3(ii) 
Seen by a western doctor (西醫) Go to 3 ( i i )~ 
Seen by a Chinese medicine practitioner (中醫師) Go to 3 ( i i )~ 
Others, please specity: Go to 3 ( i i )~ 
3(i) (If selected no treatment) Why didn't you take any treatment? (can choose more 
than one item) 
No need, illness would recover sooner or later 
Flu and flu-like illnesses could not be cured by treatment 
No time to go for treatment 
Treatments are too expensive 
Treatments are not effective 
Others, please specify 
3(ii) If selected "treatment", what was/were the reason (s)? (can choose more than one 
item) 
Could not stand the symptoms 
Hoped to recover sooner 
To prevent complications 
To treat complications 
To prevent infecting others 
Others, please specify 
4. To what extent were your normal activities affected? (please insert • in the 
appropriate boxes) 
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At the onset: 5 to 7 days later: 










Total number of days of sick leave taken = days 
5. What was the total duration of your illness with respect to the severity of 
symptoms and the effect on work capacity? 
Symptoms: “ Days 
~ ( a ) Mild symptoms (normal activities not affected) for 
(b) Moderate symptoms (normal activities atfected) tor 
~ ( c ) Severe symptoms (need tor bed rest and sick leave) for 
^ T o t a l duration = (a)+(b)+(c) 
Work capacity a f f e c t e d : “ Days 
(i) Not affected tor 
(ii) Mildly aftected tor 
(iii) Moderately attected tor 
(iv) Severely attected tor 
Total duration = (i)+(ii)+(m)+(iv) 
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6. (a) Were you admitted to hospital for reasons directly related to this episode? 
(please insert • in the appropriate box) 
n Yes • No • (Go to question 7) 
(b) If yes, what was the diagnosis? (please insert • in the appropriate box) 
n Severe flu (嚴重感冒） 
n Pneumonia (肺炎） 
n Others, please specify: 
(c) If yes, duration of hospital stay = days 
7. (Por air crew only) Did you develop this flu episode during or after a trip to a 
foreign city? (please insert • in the appropriate box) 
n No 
n Yes. Can you recall to which city? 
n City in the mainland 
n City in South East Asia 
n City in Japan, South Korea, and Taiwan 
n City in Australia and New Zealand 
n City in the United States and Canada 
n City in Europe 
n City in other areas, please specify: 
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Part III: Background information 
In each of the following, please insert • in the appropriate box. 
1. Sex: n Male • Female 
2. Age: • <18 n 18-25 •26-30 nSl-SS 
• 36-40 n41-45 n 46-50 n > 5 0 
3. Smoking experience: 
n Current smoker • Ex-smoker • Never smoked 
4. Are you having nasal diseases(鼻部疾病）requiring regular medications? 
n Yes • No 
5. Are you having lung/airways diseases(肺部/ 呼吸道疾病）requiring regular 
medications? 
n Yes n No 
6. On average, how many hours are you spending per week on physical exercise? 
n <1 hour 
n 1 to 2 hours 
n 2 to 6 hours 
n >6 hours 
7. Annual income (HK$): 
n <50,000 • 50,000-100,000 n 100,000-200,000 
n 200,000- 400,000 n 400,000 - 800,000 n 800,000 -1,600,000 
n >1,600,000 
8. You belong to the (check one only): 
n Cabin crew • Cockpit crew 
• Clerical staff • Managerial staff 
n Check-in staff n Technical staff 
* * * e n d * * * 
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